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ABSTRACT
Tumor cells are well known to exhibit ER stress as a result of their altered environment
characterized by redox and calcium imbalance, deregulation of protein synthesis to meet
their oncogenic demands, and decreased vascularization associated with nutrient limitation
and hypoxia, all of which are conducive of ER stress. Accordingly, markers of ER stress
signaling response are up-regulated in various cancers. The outcome of ER stress signaling
response varies from survival and adaption to apoptosis. Although pro-apoptotic ER stress
signaling molecules are up-regulated in cancer, the mechanisms by which cancer cells seem
refractory to, or evade, their apoptotic signaling are not fully understood. In this study, we
investigate roles of the mammalian Ecdysoneless (ECD) in ER stress and oncogenesis.
Certain tumors overexpress ECD protein suggesting possible roles in oncogenesis. In fact,
both normal and cancer cells require ECD for their growth and undergo cell cycle arrest
when the ECD level is deficient. ECD associates with various stress response proteins such
as p53, well known for genotoxic stress response such as DNA damage, and TXNIP, an
oxidative stress protein recently implicated in ER stress response. Furthermore, ECD is a
critical component of chaperone-like complexes such as the R2TP complex whose
members have ER stress-related roles. In this study, we provide evidence that ECD is
involved in ER stress.
Stress induction by multiple stimuli, including Thapsigargin, Tunicamycin, glucose
starvation, H2O2, NOX4 overexpression, led to reduced ECD protein levels, but ECD
mRNA increased, in a PERK-eIF2α dependent manner. Although a phospho-protein, ECD
is not a target for a phosphorylation-mediated degradation by PERK but is rather targeted
for a translation block via the PERK-eIF2α axis. To assess the functional connection
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between ECD and ER stress signaling pathways, we used cells in which ECD could be
inducibly depleted or overexpressed. Depletion of ECD enhanced PERK signaling and
apoptosis upon ER stress induction while overexpression of ECD produced the opposite
effect by inhibiting PERK signaling and increasing cell survival. IRE1α signaling was
slightly affected by these changes in the cellular level of ECD, as indicated by the slight
increase or decrease of its downstream target, spliced XBP-1, upon ER stress induction in
the presence or absence of ECD; on the other hand, the ATF6 pathway was minimally
affected.
Based on these findings, we examined the possible mechanism by which ECD regulates
ER stress signaling, particularly the PERK pathway. We found that ECD co-localized and
associated with all the ER stress sensors PERK, IRE1α, ATF6 and GRP78. However, ECD
does not modulate the enzymatic activity of PERK toward its substrate eIF2α. Rather, ECD
enhanced chaperones’ levels, predominantly, GRP78 upon ER stress induction. Finally,
disruption of this chaperone-enhancing effect of ECD abrogated the attenuating effect of
ECD on PERK and impaired the pro-survival effect of overexpressed ECD upon ER stress
induction. Taken together, ECD regulates the levels of chaperones, predominantly, GRP78
to enhance the folding capacity of the stressed ER and provide survival advantage in a
stress condition.
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CHAPTER ONE: INTRODUCTION
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1.1 Overview of the Endoplasmic Reticulum (ER) and its functions in the cells

The Unfolded Protein Response (UPR), a term used interchangeably with
Endoplasmic Reticulum (ER) stress response, is a reference to stress in the ER which is a
membrane-bound sub-cellular organelle interconnecting other organelles (1), including
the Golgi apparatus, the lysosome, the mitochondria and the nucleus. It is the largest
organelle and the site for many central cellular functions such as synthesis, folding and
maturation of secreted and membrane proteins, biogenesis of cholesterol, and calcium
storage. Different classes of proteins mediate these functions of the ER; key among them
are proteins involved in translation. In eukaryotic cells, translation occurs directly in the
ER, following assembly and translocation of the ribosomal complex to the translocation
channel. This complex is composed of the eukaryotic initiation factor 2 alpha (eIF2a) in a
ternary complex with bound GTP and the methionine initiator tRNA (Met-tRNAi-eIF2aGTP) (2). As the newly synthesized proteins enter the ER, they undergo post-translational
modifications (PTM) in an oxidative environment. Examples of common PTM are
glycosylation, disulfide bond formation and phosphorylation. Proper PTM precedes
proper folding of proteins into their three-dimensional structure with the assistance of ER
resident chaperones such as the Glucose-Regulated Protein 78/ Immunoglobin Binding
Protein (GRP78/ Bip), GRP94, calreticulin, calnexin and protein disulfide isomerases or
PDI (3). The PDIs, in particular, are oxygen-requiring ER oxidoreductase 1 (Ero1)
enzymes which generate disulfide bonds de novo and transfer them to their thioredoxin
motif containing the thiol/disulfide oxidoreductase site (4). Lastly, the ER chaperones are
calcium binding proteins and function calcium-dependently, justifying why the ER is also
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the main calcium storage in the cell, with ATP-dependent calcium pumps which influx
calcium from the cytosol to the ER. The ER also participates in intra and extracellular
calcium signaling (5).

1.2 Physiological and pathological conditions that perturb ER homeostasis and
induce stress
Physiological conditions that induce stress in the ER, such as glucose deficiency,
are cell type specific. Glycosylation, a critical PTM, is disrupted when cells are glucosedeprived, as a result of a decreased level of glycosyl group in the cells (6). Moreover,
glucose deficiency also decreases ATP level in the cells, impairing crucial functions of
ATP-dependent calcium pumps in the cells (6). High glucose also perturbs proper ER
function in secretory cells, such as pancreatic beta cells, due to the ensuing increased
production of insulin that must be processed through the ER. Other physiological
perturbants that induce ER stress are calcium deprivation, which impairs the function of
key ER chaperones, free fatty acids and cytokines. In pancreatic beta cells, the best model
for studying ER stress, ER stress can be physiologically induced by mutant insulin (6).
Thus, pathological conditions that cause increased blood glucose levels, such as diabetes,
induce ER stress (7). Viral infection is another type of pathological ER stress inducer
because of the increased synthesis of viral proteins that must be processed in the host ER.
Ischemia, the loss of blood supply to body organs, is also known to induce ER stress (8).
Finally, in order to support proper protein folding, the ER environment is highly
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oxidative and is sensitive to change in the reduction-oxidation (RedOx) state of the cell
(9).
1.3 Upstream signaling pathways of the ER stress response

ER stress is a condition in cells characterized by protein load in the ER exceeding
the folding capacity of the ER. It can be caused by any of the physiological or
pathological conditions mentioned above. Additionally, pharmaceutical agents such as
Thapsigargin, Tunicamycin, Brefeldin A, Dithiothreitol and hydrogen peroxide also
induce ER stress. Perturbation of the ER function elicits a response termed the unfolded
protein response (UPR). The UPR is an adaptive pro-survival response in its initial phase
but shifts to a pro-apoptotic response when the stress becomes overwhelming (10-12).
Three canonical pathways mediate these two phases of the UPR of which PERK (PKRlike ER Kinase), IRE1α (Inositol Requiring Enzyme 1 alpha) and ATF6 (Activation of
Transcription Factor 6) are the upstream players.
PERK is an ER transmembrane kinase with luminal, transmembrane and
cytoplasmic domains. The cytoplasmic c-terminal kinase domain of PERK is activated by
homo-dimerization of the protein followed by auto-phosphorylation (10,13,14). The
active PERK kinase phosphorylates the eukaryotic initiation factor 2 alpha (eIF2a) (15),
altering its conformation and leading to a gradual disassembly of the ternary Met-tRNAieIF2a-GTP complex, a critical part of the active translation complex. The resulting
inhibition of the translation machinery causes a decrease in the load of protein entering
the ER lumen (15) as well as cell cycle block, allowing cells time to solve the stress in
the ER. Although global cap-dependent translation is blocked, a cap-independent
translation of specific ER stress response genes proceeds. One such cap-independently
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translated protein is Activation of Transcription Factor 4 (ATF4) (15), a transcription
factor of the same family as ATF6. ATF4 translocates into the nucleus to activate a
transcription enhancer gene, the CCAAT-enhancer-binding protein homologous protein
(CHOP), which sensitizes cells to ER stress-induced cell death by multiple mechanisms
including a down-regulation of the pro-survival Bcl-2 (B-Cell Lymphoma 2) protein
family while increasing levels of members of the death receptor protein family.
Moreover, CHOP is known to down-regulate glutathione levels, the cell’s anti-oxidant
defense protein, leading to a surge in the levels of reactive oxygen species (ROS), a
subsequent release of cytochrome c into the cytoplasm and activation of the caspase
cascade, culminating in cell death (15-19). Concurrently, CHOP activates another
protein, GADD34 which, together with the type 1 protein phosphatase (PP1), targets
eIF2α for de-phosphorylation and resumption of protein synthesis (20-24). Alternatively,
this recovery from the stress-induced translation block is also achieved in cells by cellular
PERK inhibitor p58 IPK (25,26).
IRE1 exists in two isoforms, IRE1α and IRE1β. IRE1α, the widely studied
isoform, has both kinase and RNAse function. Like PERK, it is activated by dimerization
and auto-phosphorylation. With the RNAse activity, it is known to splice a 26 nucleotide
intron from the X-box binding protein 1 (XBP-1) (16,27-30) to generate an active
transcription factor, which translocates to the nucleus to activate ER response genes, one
of which is the ER degradation-enhancing protein (EDEM) (16,31). In severe ER stress,
EDEM activates the massive degradation of misfolded and unfolded proteins, termed ERassociated degradation (ERAD) (32,33), a process involving ER chaperone-mediated
retro-translocation of proteins to the cytoplasm for proteasomal degradation. The RNAse
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function of IRE1α is also associated with a degradation of ER-associated mRNA in a
process termed RIDD or regulated IRE1α-dependent decay (34,35) to further inhibit
protein translation into the stressed ER. With the kinase function, IRE1α is known to
recruit TRAF2 (TNF-receptor activating factor 2) to activate the apoptosis-signaling
kinase 1 (ASK1) and the Jun N-terminal Kinase (JNK), leading to caspase cascade and
cell death (11,36).
ATF6, like IRE1, exists in two isoforms, ATF6α, the most studied isoform, and
ATF6β. Upon ER stress signaling, ATF6α translocates to the Golgi apparatus where it is
proteolytically cleaved by the Golgi Site 1 & 2 proteases (SP 1&2) (37,38) to generate an
active transcription factor which translocates into the nucleus to activate ER stress target
genes. ATF6α activates expression of chaperones upon ER stress, including GRP78,
GRp94 (39).

1.4 The ER stress in Cancer: a paradox

The ER stress is the basis of diseases collectively referred to as ER stress diseases,
including heart diseases, neurodegenerative diseases, diabetes and cancer (40). With regard
to cancer, the ER stress response is known to promote survival mechanisms in cancer,
hence driving oncogenesis. The tumor microenvironment is indeed a very hostile
environment, characterized by Redox imbalance (41,42)], deregulated protein synthesis
(43), and decreased vascularization associated with hypoxia and hypoglycemia (44), all of
which are conducive to ER stress. Cancer cells also generate a higher level of hydrogen
peroxide, a precursor of reactive oxygen species (ROS) which also perturbs ER
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homeostasis. As such, markers of the ER stress response are up-regulated in various
cancers [22], suggestive of fully activated and operational ER stress signaling to drive
tumor progression. For instance, X-Box binding Protein 1(XBP1) promotes survival in
triple negative breast cancer by enhancing the hypoxic response pathway (45) while CHOP
drives hepatocellular oncogenesis by promoting oncogenic cell growth (46). In the same
vein, the chaperone GRP78 promotes tumor survival, metastasis, angiogenesis and
resistance to a wide variety of therapies (47,48).
Controversially, components of the ER stress response are also implicated in
negative regulatory control of tumor growth. In this context, activated PERK has been
known to induce proliferation block via multiple mechanisms including blocks in DNA
synthesis and protein translation (49-53). Moreover, expression of PERK leads to tissue
atrophy in Drosophila melanogaster, a phenotype that was corrected by co-expressing
GADD34, the phosphatase that represses PERK signaling (54). Although there are
conflicting reports as to the role of PERK in tumor progression, the PERK pathway has a
strong potential to reduce the growth of tumor cells (55). Besides PERK, a second
possibility exists for the ER stress signaling to regulate tissue growth through ATF4
which has also been shown to negatively control neurogenesis in the developing mouse
brain (56). ATF4 levels change during cell cycle progression and the protein undergoes a
phosphorylation-dependent degradation required for cell cycle progression (56). This
negative regulatory role of ATF4 on cell growth was observed in another study in which
overexpression of ATF4 inhibited cell proliferation and mammary gland development
(57).
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The last and third level of negative regulation of cell growth by components of the
ER stress response involves CHOP, also known as Growth Arrest and DNA-Damage
inducible (GADD153). Induction of CHOP has been reported in in vitro differentiation
experiments of 3T3-L1 cells to adipocytes, a process requiring growth arrest (58),
suggesting a connection of CHOP to growth arrest as indicated by the very nomenclature
of the protein (Growth Arrest and DNA-Damage inducible). Moreover, in tumors of
adipose tissue, a chromosomal translocation has been found to cause a fusion protein
between CHOP and a novel RNA binding protein, TLS (translocated in liposarcoma)
(59-61). The TLS-CHOP fusion protein was oncogenic (62). This oncogenic gain of
function of the mutant form of CHOP, ie TLS-CHOP, further implies an anti-oncogenic
or growth suppressive role of the wild type CHOP. In fact, microinjection of CHOP into
cells inhibited BrdU incorporation and caused proliferative block, a defect reversed by
the TLS-CHOP variant mentioned above (62). Altogether, these studies provide strong
evidence that the ER stress signaling has the capacity to both negatively and positively
affect tumor growth. However, paradoxically, although the ER stress signaling is
activated in various cancers, cells in tumors seem refractory to its growth inhibitory
signaling and only proliferate, even indefinitely. This seeming tolerance of tumor cells to
the stress-induced growth inhibitory signaling hints to the existence of mechanisms to
desensitize and protect tumor cells against the growth inhibitory effect of the ER stress
signaling.

1.5 The Ecdysoneless (ECD) protein, its oncogenic and stress-related potentials
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ECD was first identified in Drosophila as the mutation that caused a deficiency in
the steroid hormone, Ecdysone, a hormone that plays roles in normal embryogenesis,
metamorphosis and reproduction (63), all of which require cell growth and proliferation.
As a result, these ECD mutants understandably exhibited developmental defects. The
mammalian ECD was discovered from a screen of genes that could rescue the growth
defects in S. Cerevisiae mutant for the Growth Control Regulatory gene 2, GCR2
(64).This was the first indication that the mammalian ECD plays a role in growth. Studies
from my mentor’s lab provided the most direct evidence that ECD does indeed play a key
role in positively regulating cell growth and development. The lack of ECD in cells
caused cell cycle to be arrested in G1 phase, a defect that was rescued by exogenously
expressed ECD (65). The requirement of ECD for cell growth may justify its overexpression in various cancers and its association with poor prognosis and short patient
survival (66,67). In pancreatic cancer, knock down of ECD reduced proliferation and
tumorigenicity with cells arrested at G1-S phase (66). While ECD overexpression alone
did not accelerate cell proliferation, its overexpression together with Ras enhanced cell
proliferation in epithelial cells did (68). However, ECD overexpression in fibroblasts
cells induced p53 dependent cellular senescence, by p53 stabilization and positively
regulatingp53(69), implying a link to p53. Moreover, ECD interacts with p53 to stabilize
it and positively regulates its transcriptional activity (69), raising the possibility that ECD
may have a connection to p53 pathways. In addition to its tumor suppressive roles, p53 is
also related to stress such as genotoxic stress and oxidative stress. ECD may be part of
protein complexes that modulate p53 stress functions such as the oxidative stress
regulator TXNIP. ECD interacts with TXNIP and together, ECD-TXNIP increases p53
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activity (70). Similar to ECD, TXNIP interacts with p53 to increase its stability and
function under oxidative stress (71). Significantly, a recent study found an ER-stressrelated role for TXNIP in its interaction with PDI (Protein Disulfide Isomerase) to
increase their enzymatic activity during ER stress thereby reducing stress (72).
Furthermore, TXNIP is implicated in ER stress response as a novel component of the
stress response signaling to mediate the inflammation-related axis of the stress-induced
apoptosis (73). Also, TXNIP may also regulate the physiological function of the ER
because it is part of the cellular redoxisome, comprising Thioredoxin, which regulates the
redox state of the cell including the redox environment in the ER. The PDIs mentioned
above are redox-sensitive ER oxidoreductases with Thioredoxin motifs and changes in
the ER oxidative environment impair their functions (4).
Lastly, we and others have recently shown that ECD associates with R2TP
complex (74,75). The R2TP complex is involved in the assembly and remodeling of large
protein-protein or protein-RNA complexes, such as RNA polymerase, small nucleolar
ribonucleoproteins (snoRNPs), and phosphatidylinositol 3-kinase-related kinases
(PIKKs) (76). Our recent study showed that the N-terminal region of ECD associates
with the RUVBL1 component of the R2TP complex and both the phosphorylation and
interaction of ECD with RUVBL1 are required for ECD’s role to promote cell cycle
progression (75). The R2TP has an ER stress-related role through its RUVBL2
component (77). Notably, RUVBL2, or TIP49b has been shown to inhibit the activity of
ATF2 (77), a downstream target of PERK signaling, suggesting a role of the R2TP
complex component in ER stress. Overall, the multiple lines of evidence presented above
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suggest some connection of ECD to ER stress. In my thesis, I investigated in detail
whether ECD regulates ER stress.
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CHAPTER TWO: Mammalian ECD protein functions as a novel negative regulator
of the Unfolded Protein Response
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2.1 Overview
The mammalian Ecdysoneless (ECD) is a highly-conserved ortholog of the Drosophila
ECD gene product whose mutations impair the synthesis of Ecdysone and produce cellautonomous survival defects but mechanisms by which ECD functions are largely
unknown. This study presents evidence that ECD regulates endoplasmic reticulum (ER)
stress response. Stress induction by multiple stimuli, Thapsigargin, Tunicamycin, glucose
starvation, H2O2, NOX4 overexpression, DTT, and sorbitol, led to reduced ECD protein in
levels in multiple cell lines (MCF7, MDA-468, MCF10A, Panc-1, 76NTERT, MDA231NOX4). However, contrary to the decrease in ECD protein levels, ECD mRNA increased
upon Thapsigargin treatment suggesting that the decrease in ECD protein is not at
transcriptional level. To elucidate the ER stress signaling pathway regulating ECD protein
levels, we induced ER stress in MEF cells in which the three ER stress pathways, PERK,
IRE1α and ATF6, had been individually abrogated to produce single knock out (KO)
MEFs. In IRE1α KO and ATF6 KO MEFs, the decrease in ECD protein levels was
comparable with the control WT MEFs upon ER stress induction. However, in PERK KO
MREFs, the levels of ECD protein did not change upon ER stress induction as compared
to WT PERK. Furthermore, in PERK KO MEFs, ECD mRNA levels failed to increase,
suggesting that the decrease in ECD protein and the increase in ECD mRNA may be tied
to PERK activity. Since ECD is a phospho-protein and certain proteins undergo a
phosphorylation-dependent degradation, we first tested the hypothesis that the decrease in
ECD protein levels is PERK phosphorylation mediated. To assess that possibility, we
performed an in vitro kinase assay to examine the potential that ECD could be a substrate
for phosphorylation by PERK, a kinase. However, we did not find that ECD was
phosphorylated by PERK. The second hypothesis for the decrease in ECD protein levels
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was that ECD protein translation was blocked by PERK phosphorylation of eIF2α. To test
that hypothesis, we induced ER stress in phospho-deficient eIF2α MEFs and found that the
decrease in ECD levels upon ER stress induction was abrogated just as in PERK KO
MEFS. The results suggested that ECD protein levels are reduced via the PERK-eIF2α axis
of the ER stress signaling and that ECD may be functionally linked to that PERK-eIF2α
axis. To examine that possibility, we resorted to cells in which ECD could be inducibly
depleted or overexpressed. Depletion of ECD increased the levels of p-PERK, p-eIF2α,
and these effects were enhanced upon ER stress induction by Thapsigargin treatment or
glucose deprivation along with an increase in CHOP mRNA, and cleaved caspase 3. A
slight increase in the levels of spliced XBP-1, the downstream target of IRE1α, was also
observed but cleaved ATF6 did not significantly change. These effects correlated with a
decrease in the colony formation of the ECD-null cells. Reciprocally, overexpression of
ECD led to a marked decrease in p-PERK and its downstream targets, p-eIF2α, ATF4 and
CHOP mRNA levels. Spliced XBP1 levels were slightly decreased while ATF6 did not
change significantly. These effects correlated with a decrease in caspase 3 cleavage and an
increase in the colony forming ability of the ECD overexpressing cells. Taken together,
these results suggested that ECD functions as a repressor of stress signaling, particularly
as a negative regulator of PERK signaling and that ECD and PERK are linked through a
negative feedback mechanism whereby ECD inhibits PERK while, when activated, PERK
inhibits ECD protein by blocking its translation.
Based on the findings presented above, we sought to investigate the possible mechanisms
by which ECD regulates ER stress signaling, particularly the PERK pathway. First, we
examined the localization of ECD relative to the upstream mediators of the ER stress
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signaling and found that ECD localized and associated with PERK, ATF6, IRE1α and
GRP78. To assess whether ECD directly regulates PERK signaling, we performed in vitro
kinase assay of PERK with eIF2α in the presence of an increasing concentration of the
ECD protein. However, ECD did not modulate enzymatic activity of PERK toward eIF2α.
Since induction of chaperones during ER stress signaling is well known as a homeostatic
mechanism aimed at restoring the ER function by clearing the stress stimulus, we next
examined the effect of ECD on levels of chaperones, particularly GRP78 which is the major
regulator of PERK signaling. We found that the levels of GRP78 (GRP94 and PDI to a
lesser extent) were dependent on ECD and that depletion or overexpression of ECD
decreased or increased GRP78 protein levels, respectively, upon ER stress induction.
However, GRP78 mRNA was not affected, suggesting a post-translational effect. To
determine whether a change in the levels of ECD affects GRP78 protein stability, we
deleted ECD followed by cycloheximide treatment and found that the decrease in GRP78
protein level was faster in ECD-null cells. Reciprocally, in ECD overexpressing cells, the
decrease in the levels of GRP78 protein was slower upon cycloheximide treatment. Finally,
to determine whether GRP78 was required for ECD effects on PERK signaling, we
knocked down GRP78 and found that even in the presence of overexpressed ECD, a knock
down of GRP78 abrogated the attenuating effect of ECD on PERK, correlating with a
decrease in colony formation of the ECD overexpressing cells. Taken together, these
results argue that ECD enhances the levels of chaperones, predominantly, GRP78 to
enhance the folding capacity of the stressed ER and reduce stress.
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2.2 INTRODUCTION
The endoplasmic reticulum (ER) is a central subcellular organelle with essential roles in
the synthesis, folding and maturation of secreted and membrane proteins, biogenesis of
cholesterol, calcium homeostasis and regulation of survival and apoptosis pathways (1-10).
Aberrations in these ER functions are sensed by well-conserved ER transmembrane
sensors, Inositol-Requiring Enzyme 1 alpha (IRE1α), PKR-like ER kinase (PERK) and
Activating Transcription Factor 6 (ATF6), that activate homeostatic signaling pathways
collectively referred to as the unfolded protein response (UPR) (11,12). These ER stress
sensors exhibit a dynamic and reversible interaction with the ER chaperone GRP78 (13).
In un-stressed cells, GRP78 is bound to luminal domains of UPR sensors, which maintains
them in an inactive state (14). During ER stress, the increased load of unfolded proteins
competes for GRP78 binding, leading to activation of UPR sensors (15).
As an important chaperone, the level of GRP78 is also increased during ER stress
signaling, mainly via the ATF6 pathway (16). The induction of GRP78 and other
chaperones such as GRP94 (17-19) and PDI (20,21) is a homeostatic mechanism to
restore normal functions in the ER and protect cells from stress-induced cell death. Part
of GRP78’s cyto-protective role involves its regulation of the ER stress sensors during
stress signaling to prevent their hyper-activation and ensuing cell death. To achieve that
effect, GRP78 is known to reversibly bind the ER stress sensors, when induced, and
inhibit their signaling (13). Consequently, overexpression of GRP78 has been shown to
inhibit PERK signaling, in particular (13). Furthermore, GRP78 has been shown to
physically interact with caspases (22) and prevent their cleavage (23).
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The GRP78 protein is known to contain the canonical KDEL ER retention signal
(24,25) which allows it to be retro-transported from the Golgi to the ER during its
journey through the secretory pathway. Accordingly, GRP78 was traditionally thought of
as an ER-resident protein. However, recent evidence points to a ubiquitous nature of the
protein in cells. GRP78 has been found in the cytoplasm where it interacts with
cytoplasmic proteins such as caspace-7 and clusterin protein (22,26); there is also
evidence of GRP78 presence in the nucleus and mitochondria (27). This ubiquitous
nature of GRP78 in cells suggests that the ER functions of GRP78 may not necessarily
require its ER- localization, especially as studies have identified a cytoplasmic, nonKDEL containing variant of the GRP78 protein which still has ER stress-related
functions via cytoplasmic regulators of the ER stress signaling (28).
The PERK pathway has emerged as a key pathway in cellular UPR response as well
as homeostasis under unstressed conditions and in disease states (29-34). Release of
GRP78 from PERK leads to its dimerization, auto-phosphorylation and activation
(15,35,36). A major PERK substrate is the eukaryotic translation initiation factor 2 alpha
(eIF2α) whose phosphorylation by PERK inactivates it leading to a block in general capdependent protein translation and consequent decrease in the protein load entering the ER
(37); concurrently, PERK signaling selectively enhances the cap-independent translation
of specific mRNAs, such as Activating Transcription Factor 4 (ATF4) (37). ATF4 induces
the expression of CCAAT/enhancer-binding protein-homologous protein (CHOP) which
promotes apoptosis in response to stress (37-45). PERK-induced phosphorylation of eIF2α
also inhibits cell cycle progression by reducing the levels of cyclins and hence cyclindependent kinase 2 (CDK2) activity (46-48). Termination of PERK signaling, together

35

with de-phosphorylation of eIF2α, is required to re-initiate protein synthesis and resume
the cell cycle. Thus, PERK-mediated UPR leads to a coordinated program of cellular
protection and mitigation of stress. However, PERK also contributes to an alternate
outcome through CHOP-mediated activation of a cellular death pathway to eliminate
severely damaged cells (37-45). Mechanisms to fine-tune the outcomes of UPR pathways
are important to mitigate the negative consequences of ER stress. This is of particular
importance under conditions where cells experience ER stress as part of their physiological
responses, such as antibody-secreting plasma cells or insulin-secreting pancreatic islet cells
(49). We have identified ECD as a negative regulator of the PERK-mediated UPR.
The ECD gene was first identified based on genetic mutations in Drosophila that lead to
reduced production of the developmentally-regulated steroid hormone Ecdysone, which is
synthesized in the ER, hence the designation of Ecdysoneless for such fly mutants (50).
The mammalian ECD gene was cloned based on the rescue of growth defects in S.
cerevisiae mutant in the growth control regulatory gene 2 (GCR2), a glycolysis regulatory
gene (51). Thus, ECD was thought to be involved in mammalian glycolysis gene
expression and initially named hSGT1 (human suppressor of gcr2)(51). My lab identified
the same gene in a screen for interacting partners of human papilloma virus E6 oncoprotein
and found it to interact with p53 and transactivate p53-regulated genes (52,53).
To elucidate the functional role(s) of mammalian ECD, my lab generated ECD-null mice
and demonstrated that homozygous deletion of ECD was early embryonic lethal while ex
vivo Cre-mediated deletion of ECD in ECDfl/fl mouse embryonic fibroblasts (MEFs) led to
proliferative block and a significant decrease in cell survival (54,55). ECD was found to
be essential for E2F target gene expression by facilitating the dissociation of the
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retinoblastoma RB protein

from E2F and promoting the G1-to-S phase cell cycle

progression (54). As a consequence, ECD-null MEFs showed a decrease in the levels of
cyclins A, B1, E and D1, reduction in CDK2 kinase activity and were arrested in G1 phase
of the cell cycle (54). Interestingly, E2F family proteins such as the E2F1 have been
implicated in UPR-mediated cell death (56). In addition to its promotion of the G1/S phase,
ECD also promotes G2/M phase of the cell cycle and its knockdown induced not just a
G2/M arrest but also apoptosis (57). Induction of UPR not only induces apoptosis but also
halts cell cycle progression in G1 and G2 phases (46-48,58) and these effects are mediated
by PERK (46,47), suggesting a potential connection between ECD and the PERK arm of
the UPR.
More recently, we uncovered another mechanism by which ECD regulates cellular
proliferation, through its interaction with RUVBL1 and PIH1D1 components of the
prefoldin co-chaperone R2TP (55) which is involved in the assembly or remodeling of a
number of protein and protein-RNA complexes to regulate many physiological processes
(59-65). Recently, it was reported that knock down of the RUVBL1 component of the
R2TP complex induced cell cycle block and ER stress (66). Furthermore, ECD has been
shown to associate with the stress response protein Thioredoxin-Interacting Protein
(TXNIP) (67) which is known to bind to the ER chaperone PDI (protein disulfide bond
isomerase) to increase its enzymatic activity to relieve ER stress (20). Lastly, TXNIP was
recently shown to be a novel component of the UPR and is regulated by the PERK pathway
(68). Based on these multiple lines of suggestive evidence pointing to a potential role of
ECD in the regulation of ER stress, we investigated ECD and demonstrated that it
modulates ER stress signaling, particularly the PERK arm. Induction of ER stress, using
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both chemical ER stress inducers (Thapsigargin and Tunicamycin) and physiological ER
stress inducers (glucose starvation), led to a reduced level of the ECD protein, and this
effect was not seen in PERK KO or phospho-deficient eIF2α MEFs. Notably, ECD mRNA
levels were increased, suggesting impaired ECD translation as a mechanism for reduced
protein levels. ECD depletion increased the levels of p-PERK and its downstream targets,
p-eIF2α and CHOP mRNA while ECD overexpression markedly decreased their levels
upon ER stress induction. Spliced XBP-1, the downstream target of IRE1α and cleaved
AFT6 were slightly affected. Significantly, ECD overexpression and depletion distinctly
affected the survival outcome of cells upon ER stress. Additionally, we found that the
levels of GRP78 (GRP94 and PDI to a lesser extent) were dependent on ECD and that
depletion or overexpression of ECD decreased or increased GRP78 protein levels,
respectively, upon ER stress induction. However, GRP78 mRNA was not affected,
suggesting a post-translational effect.

Deletion of ECD followed by cycloheximide

treatment showed that the decrease in GRP78 protein level was faster in ECD-null cells.
Reciprocally, in ECD overexpressing cells, the decrease in the levels of GRP78 protein
was slower upon cycloheximide treatment. Finally, to determine whether GRP78 was
required for ECD effects on PERK signaling, we knocked down GRP78 and found that
even in the presence of overexpressed ECD, a knock down of GRP78 abrogated the
attenuating effect of ECD on PERK, correlating with a decrease in the colony formation of
the ECD overexpressing cells. Taken together, these results argue that ECD enhances the
levels of chaperones, predominantly, GRP78 to enhance the folding capacity of the stressed
ER and reduce stress.
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2.3 MATERIALS AND METHODS
Reagents and antibodies
Thapsigargin, (Cat# 12758) and Tunicamycin (Cat# 12819) and Brefeldin A (cat# 9972)
were from Cell Signaling and dissolved in DMSO. Dithiothreitol (cat# 9776), Sorbitol
(cat# 1876) and Hydrogen Peroxide (cat# H1009) were from Sigma. A monoclonal
antibody against ECD, generated in our laboratory, has been described previously (69).
Antibodies against p-PERK (cat# 3179), ATF4 (cat# 11815), p-eIF2α (cat# 9721), eIF2α
(cat# 9722), Caspase 3 (cat# 9662), s-XBP1 (cat# 12782), IRE1α (cat# 3294), GRP78 (cat#
3177), p-SAPK/JNK (cat# 9251) and total PERK (cat# 3192) were from Cell signaling.
ATF6 antibody was purchased from Enzo Life (cat# ALX-804-381-C100).

Cell lines and culture conditions
ECD inducible MEFs were generated from the lab. 13.5 days old embryos of mice of the
genotype Tet(O)-Flag-hECD-IRES-eGFP were used. rtTA was introduced retrovirally to
generate Tet(O)-Flag-hECD-IRES-eGFP; rtTA.

ECD

fl/fl

MEFs were maintained in

DMEM medium supplemented with 10% fetal bovine serum and treated with adenoviruses
coding for GFP (adeno-GFP, control) or Cre (adeno-Cre) as described previously (54,55).
The culture condition for the ECD inducible MEFs was same as the ECD fl/fl MEFs. Panc-
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1 cells have been previously described (70). For ECD overexpression studies, control
MEFs or ECD over-expressing MEFs were cultured with 1μg/ml of Doxycycline (Cat #
231286, BD Biosciences) to induce expression of the ECD transgene. MEFs with a nonphosphorylatable eIF2α were obtained from Dr. Thomas Rutkowski’s lab, Carver College
of Medicine, Iowa and has been described elsewhere (71). PERK knockout (KO) MEFs
were from ATCC (CRL-2976) while IRE1α KO and ATF6 KO were gifts from Dr. Urano’s
lab, Washington University St. Louis and Dr. Hendershot’s lab, St. Jude Children Research
Hospital, Tennessee, respectively. Immortal mammary epithelial cell lines MCF-10A,
76NTERT were from the lab and was cultured in DFCI-1 medium (55). Cancer cells line
MCF7 and MDA-468 were cultured in alpha media. NOX4 expressing MDA-231 were
obtained from Dr. Teoh-Fitzgerald’s lab (UNMC, Biochemistry).

Western blotting
For western blotting, cell lysates were prepared in RIPA buffer (Cat# 89901, Thermo
Scientific) supplemented with protease inhibitors (Roche, Cat# 11836145001). Lysates
were resolved on SDS-PAGE gel, transferred on to nylon membrane (IPVH00010,
Millipore), and subjected to ECL-based Western blotting as described (54,55).
Colony Formation Assay- For clonogenic assay, 1,000 cells were plated in triplicate and
allowed to attach to the plate (about 8 h) followed by treatment with Thapsigargin for 24h.
10 days later, colony formation was assessed as previously described (54,55).
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In vitro kinase assay-A total of 500 ng of purified recombinant ECD proteins or its
mutants was incubated with 0.2 mM ATP, 1 µCi of [32P]ATP (Perkin-Elmer), and 0.2 µl
(10 U) of human recombinant PERK or CK2 (NEB, Beverly, MA) at 30°C for 30 min.
The reaction was stopped by adding SDS-PAGE sample buffer. The 32P-labeled proteins
were detected by autoradiography after SDS-PAGE and then transfer to polyvinylidene
difluoride (PVDF) membranes (Millipore).

Induction of ER stress by glucose starvation- Panc-1 cells were maintained in DMEM
supplemented with 10% fetal bovine serum and then switched to glucose-free DMEM
medium (cat# 11966-025, life technologies) for indicated times.

Statistical analysis- for assessment of statistical significance, a Student t test was used. P
values of < 0.05 were considered statistically significant

RNA isolation and real-time quantitative PCR (qRT-PCR)
Total RNA was isolated using the TRizol reagent (Invitrogen cat# 15596018). 1 µg of
RNA was reverse- transcribed using SuperScript TMII reverse transcriptase (Invitrogen
cat# 18064014). The qPCR was performed with primer sets indicated in the table
belowbelow:
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Gene

Forward primers

Mouse CTGCCTTTCACCTTGGAGAC

Reverse primer
CGTTTCCTGGGGATGAGATA

CHOP
Huma

CATTGCCTTTCTCCTTCGGG

CCAGAGAAGCAGGGTCAAGA

n
CHOP
Mouse CCGGTCTGGCACAAACTTCTGC

AGGGTCGAAGCATCCCTCCATC

ECD

TG

GA

Huma

ACTTTGAAACACACGAACCTGG

TGATGCAGGTGTGTGCTAGTTC

n

CG

CT

ECD
Mouse AGTGGTGGCCACTAATGGAG
GRP7
8

CAATCCTTGCTTGATGCTGA
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2.4 Results
2.4.1 Effect of ER stress induction by Thapsigargin, Tunicamycin, Brefeldin A on
ECD protein levels in MCF-7, MDA-468 and MCF-10A
To begin to explore the potential link of ECD to stress pathways, we assessed the effects
of various chemical ER stress inducers on ECD protein levels. For this purpose, cancer
cell lines MCF7 and MDA-468 and normal mammary epithelial cell line MCF-10A were
treated with Thapsigargin, Tunicamycin and BFA, and ECD protein levels were analyzed
by western blot. Treatment with either chemical increased the levels of eIF2α
phosphorylation, a marker of ER stress (Figure 2.1A-C). ECD protein levels did not
change much in MCF7 and MDA-468 cells with either chemical but the levels decrease
more dramatically in MCF-10A (Figure 2.1 A-C)
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MCF7

A
UT

Tg

Tun

BFA

ECD
p-eIF2α

β-actin

MDA-468
B
UT

ECD

p-eIF2α

β-actin

Tg

Tun

BFA
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MCF-10A

C
UT

Tg

Tun

BFA

ECD

p-eIF2α

β-actin

Figure 2.1 Effect of ER stress induction in MCF7, MDA-468 and MCF-10A: (A-C):
indicated cells were treated with Thapsigargin (Tg), Tunicamycin (tun) and Brefeldin A
(BFA) and equal protein was resolved on SDS-PAGE gel followed by western blot with
indicated antibodies.
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2.4.2 Physiological stress by glucose deprivation led to a decrease in ECD protein
levels
Given the effect of chemical ER stress inducers on ECD protein levels presented above,
we next assessed whether physiological stress such as glucose starvation would have
similar effects. For this purpose, we used a human pancreatic carcinoma cell line (Panc1) and mouse beta cells (MIN-6) cells both of which are known to exhibit ER stress upon
glucose starvation (21). These cells were switched from their normal complete DMEM
medium to glucose-free medium for various time points and ECD protein levels were
assessed by western blot. This glucose-free culture condition increased the levels of the
glucose-regulated protein 78 (GRP78), PERK phosphorylation (p-PERK) and p-eIF2α as
expected (21). Significantly, similar to chemical ER stress, glucose starvation-induced
ER stress also exhibited reduced levels of the ECD protein (Figure 2.2 A-B)
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ECD
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β-actin
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Time, h:

0

6
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24

48

ECD

p-PERK

p-eIF2α
β-actin

Figure 2.2: Physiological stress by glucose starvation reduces ECD protein levels:
(A-B) Human pancreatic carcinoma and mouse beta cell lines were cultured in glucosefree medium for indicated time points. Equal protein was resolved on SDS-PAGE gel
followed by western blot with indicated antibodies.
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2.4.3 Effects of other forms of stress on ECD protein levels
The effect of both chemically-induced and physiologically-induced stress on the levels
of ECD protein prompted us to further examine the effects of other stresses (oxidative,
osmotic, and reducing) on ECD protein levels. For that purpose, we first treated
MCF10A, 76NTERT and MCF7 cells with H2O2, a commonly used oxidative stress
inducer (72). Significantly, treatment with H2O2, also led to a decrease in ECD protein
levels (Figure 2.3 A). To further assess these effects, we used another type of cells
(MDA-231) which are under a physiologically-induced oxidative stress. These cells
express the NOX4 system, which generates ROS and oxidative stress (73,74) as
diagrammed in Figure 2.3 B. Again, here too, even in the absence of any exogenouslyderived stress, ECD protein levels are lower in the NOX4-expressing cells as compared
to the control cells. Reductive and osmotic stresses, by DTT and sorbitol treatment,
respectively, also led to a decrease in the ECD protein level (Figure 2.3 C-D).
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C

MCF7

MCF10A

DTT

-

+

-

+

ECD

β-actin

D

T98G

Sorbitol:

-

+

ECD

p-p38

β-actin

Figure 2.3: Effects of other forms of stress (oxidative, reductive and osmotic) on
ERCD protein level: (A) MCF-10A, 76NTERT and MCF7 cell lines were treated with
indicated doses of H2O2, (B) MDA-231 expressing NOX4 and their control cells were
lysed, (C) MCF10A and MCF7 cell lines were treated with DTT, (D) T98G cells were
treated with sorbitol. Equal protein was resolved on SDS-PAGE gel followed by western
blot with indicated antibodies.
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2.4.4 ER stress induction by Thapsigargin and glucose deprivation led to increase in
ECD mRNA levels
Given that all forms of stress led to a decrease in ECD protein levels, we assessed
whether this decrease in ECD protein levels was due to reduced ECD mRNA levels. We
treated MCF10A cells with Thapsigargin and measured ECD mRNA levels using qRTPCR. Induction of CHOP mRNA was used as a control (Figure 2.4 A). Notably, ECD
mRNA levels were not only not reduced but in fact showed an increase (Figure 2.4 B),
suggesting that the reduction in the ECD protein level was not at the transcriptional level.
Likewise, physiological stress by glucose starvation inPanc-1 cells also increased ECD
mRNA levels (Figure 2.4 D) with GRP78 mRNA induction used as control (Figure 2.4
C).
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Figure 2.4: ER stress induction by Thapsigargin and glucose starvation led to an
increase in ECD mRNA. MCF-10A cells were treated with Thapsigargin (A-B) and
Panc-1 cells were cultured in glucose-free medium (C-D), then total RNA was isolated
followed by qRT-PCR using primers against CHOP, GRP78, and ECD(Mean +/- SD and
p-values are shown from 3 independent experiments * p<0.05). CHOP and GRP78
mRNA induction served as control for Thapsigargin-induced and glucose starvationinduced ER stress, respectively.
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2.4.5 The decrease in the levels of ECD protein upon ER stress induction is PERKeIF2α dependent
Given the results above that various stresses led to a decrease in ECD protein level but
that ECD mRNA increased, we sought to determine the mechanism by which ECD
protein and mRNA levels inversely correlate. All stresses mentioned above are
interconnected. For instance, Oxido-reductive stress induces ER stress and vice versa, as
summarized in the diagram in Figure 2.3B. ER stress activates three canonical signaling
pathways summarized in Figure 1.1. To determine which pathway controls ECD protein
and mRNA levels, we induced ER stress in cells in which the upstream mediators of the
pathways (PERK, IREα and ATF6) have been genetically abrogated. For that purpose,
we used ATF6 KO, IRE1α KO and PERK KO MEFs in which the pathways have been
individually knocked out (KO). The absence of the protein was confirmed by western
blot with antibody against the protein that was knocked out (Figure 2.5A-C). In ATF6
KO and IRE1 KO MEFs, the decrease in ECD protein levels was comparable to that in
the control wild-type (Figure 2.5A-B). However, in PERK KO MEFs, the decrease in
ECD protein levels was abrogated (Figure 2.5C), suggesting that the decrease in ECD
protein levels is PERK dependent.
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Figure 2.5: The decrease in the levels of ECD protein upon ER stress induction is
PERK dependent. (A-C): Wild-type (WT) ATF6, IRE1α, PERK and their knockout
(KO) MEFs were treated with Thapsigargin and then cell lysates were resolved on SDSPAGE gels followed by western blot with indicated antibodies.
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As we previously observed that ECD mRNA increased upon ER stress induction but the
protein levels decreased, here we sought to assess whether ECD mRNA changes in
PERK WT vs. KO MEFs. Again, we treated PERK WT and KO MEFs with
Thapsigargin and measured the change in ECD mRNA by qPCR. The identity of the
PERK KO MEFs in this experiment was determined by analyzing the product of the PCR
product obtained with primers against the PERK KO domain. As shown in Figure 2.6A,
there was no PCR product in the PERK KO samples, confirming the identity of the cells.
To further confirm that, we used primers against CHOP mRNA in the qPCR. As
expected, while CHOP mRNA was induced in the PERK WT cells, the induction was
very minimal in the PERK KO cells (Figure 2.6B), since CHOP is downstream of PERK
(44). Significantly, while ECD mRNA increased in PERK WT MEFs, it did not increase
much in PERK KO MEFs (Figure 2.6C). This result that ECD mRNA failed to increase
when the protein levels didn’t change, suggests that ECD mRNA only increases when the
protein levels are down, suggesting a feedback mechanism.
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Figure 2.6: ECD mRNA levels failed to increase in PERK KO MEFs upon ER
stress. (A): PCR was performed on RNA isolated from PERK WT and KO MEFs with
primers against the KO domain. The PCR product was resolved on agarose gel. (B-C):
PERK KO and control WT MEFs were treated with Thapsigargin and total RNA was
isolated at indicated time points followed by qRT-PCR with primers against CHOP.
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To explain the PERK-dependent decrease in ECD protein levels, we proposed two
hypotheses:
1) PERK phosphorylates ECD leading to ECD degradation since (i) PERK is a
kinase, (ii) ECD is a phospho-protein as a substrate for CK2 phosphorylation and
(iii) certain proteins are known to undergo a phosphorylation-dependent
degradation (75).
2) PERK phosphorylates eIF2α to inhibit ECD protein translation since PERK is
known to inhibit translation during ER stress signaling by phosphorylating eIF2α
(37).
To investigate the first hypothesis that ECD undergoes a PERK phosphorylationdependent degradation, we first assessed whether ECD could be a substrate for PERK
phosphorylation by performing an in vitro kinase assay of ECD by PERK. EIF2α was
used as the positive control for PERK phosphorylation since eIF2α is a substrate for
PERK (37); and CK2 was used as a positive control for phosphorylation of ECD since
CK2 is known to phosphorylate ECD (55). As expected, eIF2α and ECD were
phosphorylated in vitro by PERK and CK2, respectively (Figure 2.7, lanes 1-2 and 3,
respectively). However, a phosphorylation of ECD by PERK was not observed (Figure
2.7, lane 4-5).
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Figure 2.7: PERK does not phosphorylate ECD: In vitro kinase assay of recombinant
human ECD prepared from two different sources (bacterial and insect cell derived) was
performed using human recombinant GST fused PERK. Proteins were separated by SDSPAGE, transferred to PVDF membrane, and phosphate labeling was detected by
autoradiography. Phosphorylation of eIF2α by PERK was used as the positive control for
PERK mediated phosphorylation while phosphorylation of ECD by CK2 was used as the
positive control for ECD phosphorylation.
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To investigate the second possibility that ECD translation is blocked by PERK
phosphorylation of eIF2α, we resorted to eIF2α MEFs. Since PERK activation and
subsequent phosphorylation of eIF2α mediates translational block in response to ER
stress (37), we utilized MEFs from mice that carry a serine 51 to alanine mutation in
eIF2α which prevents its phosphorylation by activated PERK and makes the cells
resistant to PERK-mediated translation block upon ER stress induction (71). As expected,
the levels of p-eIF2α increased in WT MEFs but not in the phospho-deficient eIF2α
mutant MEFs when ER stress was induced with Thapsigargin or Tunicamycin (Figure
2.8, compare lanes 1-3 with lanes 4-6). Importantly, while ECD protein levels decreased
in WT MEFs treated with ER stress inducers (Fig. 1J, compare lane 1 to lanes 2-3), the
levels of ECD protein did not change in identically-treated mutant eIF2α MEFs (Figure
2.8, compare lane 4 to lanes 5-6). Together, these results support a conclusion that ECD
protein levels are downregulated upon ER stress in a PERK-eIF2α dependent manner,
and that ER stress upregulates ECD mRNA levels, suggesting a regulatory link between
ECD and the PERK pathway of ER stress.
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Figure 2.8: The decrease in ECD protein levels is abrogated in eIF2α phosphodeficient MEFs. WT eIF2α MEFs or mutant eIF2α phospho-deficient MEFs were treated
with Thapsigargin (Tg, 50 nM) or Tunicamycin (Tun, 50 ng/ml) for 14 h and then cell
lysates were analyzed by western blotting with indicated antibodies.
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2.4.6 ECD depletion or over-expression distinctly regulate ER stress signaling upon
ER stress induction
The abrogation of the decrease and increase in ECD protein and mRNA levels,
respectively, upon disruption of PERK pathway (Figure 2.5-2.8) suggested that ECD may
be functionally linked to UPR through PERK pathway. Therefore, we assessed the
activation of the PERK pathway in the absence or presence of UPR inducers in cells in
which ECD could be inducibly deleted. For this purpose, we utilized ECDfl/fl MEFs which
have been previously established and shown to exhibit ECD gene deletion and loss of ECD
protein expression upon infection with adenovirus expressing Cre recombinase (54).
Previously, it was observed that induction of ECD deletion in these ECDfl/fl MEFs, aside
from inducing cell cycle arrest, led to a decrease in cell survival even in the absence of any
stress (54,55).
Notably, Cre-meditated deletion of ECD in the ECDfl/fl MEFs led to an increase in the
levels of phospho-PERK (p-PERK) and p-eIF2α, when compared to control adeno-GFP
infected MEFs (Figure 2.9 compare lane 1 with 3), and these effects were further enhanced
by treatment with Thapsigargin (Tg), the inhibitor of the Sarco/Endoplasmic Reticulum
Calcium ATPase (Figure 2.9, compare lane 2 with 4). Spliced XBP1, the downstream target
of IRE1α signaling also showed some increase in ECD null cells upon Thapsigargin
treatment while ATF6 did not show a significant change (Figure 2.9).
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Figure 2.9: Increased UPR in ECD-null cells upon Thapsigargin. Ecd

fl/fl

MEFs were

infected with adenoviruses coding for GFP (adeno-GFP for control) or Cre (adeno-Cre) for
72h. The cells were then left untreated or treated with Thapsigargin. Equal amount of
proteins was resolved on SDS-PAGE gel followed by western blotting with indicated
antibodies.
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Consistent with the increased p-PERK levels upon ECD deletion, Thapsigargin treated
ECD-depleted MEFs also exhibited increased expression of CHOP mRNA (Figure 2.10A),
a downstream effector of the PERK pathway whose target genes promote cell death (3741,43,44). The increased CHOP mRNA correlated with an increased cleaved caspases 3 in
ECD null cells (Figure 2.10B, compare lane 2 with 4) and a significant reduction in cell
survival, as measured by colony-forming assays (Figure 2.10C).
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Figure 2.10: ECD-null cells exhibited increased ER stress and cell death upon
Thapsigargin treatment. (A): After adenoviruses infection as described in Figure 2.9,
cells were treated with Thapsigargin. Total RNA was isolated followed by qRT-PCR with
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CHOP primers; Mean +/- SD and p-values from 3 independent experiments are indicated
* p<0.05. (B): After Adenoviruses infection, the cells were then left untreated or treated
with Thapsigargin. Equal amount of proteins was resolved on SDS-PAGE gel followed by
western blotting with indicated antibodies. (C): After adenoviruses infection as described
in (A), equal number (1,000) of wild-type (WT) or ECD-/- cells were plated in triplicate
and treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed after
crystal blue (0.5% in 25% Methanol) staining. The color retained after the wash was
dissolved in 10% acetic acid and the absorbance was read at 590 nm. The graph below
represents the relative absorbance; Mean +/- SD and p-values from 4 independent
experiments are indicated * p<0.05; ** p≤0.002
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To further assess these effects, we used physiological stress in Panc-1 cells in which ECD
was knocked down followed by glucose starvation. Again, here too, a siRNA knock down
of ECD plus glucose starvation led to an enhanced eIF2α phosphorylation, the downstream
target of PERK, and increased cleaved caspase 3 as compared to control cells (Figure 2.11,
compare lanes 1-5 with lanes 6-10), suggesting more cell death in ECD-knocked down
cells upon glucose starvation. Moreover, spliced XBP-1 levels, the downstream target of
IRE1α, were increased in ECD siRNA-treated cells as compared to the control cells
whereas ATF6 levels were comparable (Figure 2.11, compare lanes 1-5 with lanes 6-10).
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Figure 2.11: ECD knock down in Panc-1 cells upon glucose starvation led to increased
UPR and cell death. Panc-1 cells were treated with control or ECD siRNA for 48h. Then,
the cells were switched to glucose-free media and cell lysates were prepared at indicated
time points followed by western blot with indicated antibodies.
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Given the effects of ECD depletion on the UPR presented above, we used a reciprocal
approach to overexpress ECD and then examined its impact on the UPR, in particular the
PERK pathway, upon ER stress induction. To this end, and because of ongoing difficulties
overexpressing ECD in cancer cell lines, we resorted to MEFs generated in the lab from
mice that carry a Doxycycline (Dox)-inducible ECD transgene ((Tet(O)-Flag-hECD-IRESeGFP; rtTA)) or a control transgenic mouse without rtTA ((Tet(O)-Flag- hECDIRESeGFP)). These MEFs were treated with Dox to induce ECD overexpression, followed
by treatment with Thapsigargin. As expected, control MEFs exhibited an increase in pPERK and CHOP mRNA; however, the MEFs with Dox-induced ECD overexpression
exhibited a substantially reduced level of p-PERK and CHOP mRNA upon Thapsigargin
treatment as compared to control MEFs (Figure 2.12A-B).
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Figure 2.12: Decreased p-PERK and CHOP mRNA induction in ECD inducible
MEFs upon Thapsigargin. (A): ECD inducible MEFs [(Tet(O)-Flag- hECDIRESeGFP;rtTA)] or control MEFs [(Tet(O)-Flag- hECD-IRESeGFP)] were treated with
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Dox for 48 h followed by treatment with Thapsigargin. Cell lysates were prepared at
indicated time points and equal amount of proteins was resolved on SDS-PAGE gel
followed by western blot with indicated antibodies. (B): Following ECD induction and
Thapsigargin treatment as described above, CHOP mRNA levels were assessed using
qRT-PCR.

77

Likewise, when the ECD inducible MEF cell lines were treated with Thapsigargin for
various time points (3, 6, 12 or 24h), ECD overexpressing MEFs exhibited lower levels of
p-PERK compared to those in control MEFs (Figure 2.13A, compare lanes 1-5 with lanes
6-10). A corresponding reduction in the levels of ATF4, a downstream target of PERK
signaling, was seen in ECD overexpressing MEFs compared to their control MEFs (Figure
2.13A, compare lanes 3-5 with lanes 8-10); s-XBP1 and ATF6 also were slightly reduced
in ECD over-expressing MEFs (Figure 2.13A, compare lanes 1-5 with lanes 6-10). Similar
to Thapsigargin, induction of ER stress with Tunicamycin, which induces ER stress by
inhibiting glycosylation of proteins in the ER, was also associated with lower levels of pPERK and p-eIF2α in ECD overexpressing MEFs as compared to control MEFs (Figure
2.13B, compare lanes 2-5 with lanes 7-10). Taken together, these results strongly support
a conclusion that ECD negatively regulates PERK signaling.
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Figure 2.13: Decreased UPR signaling in ECD inducible MEFs correlated with in
chaperones induction upon Thapsigargin treatment. (A-B): ECD inducible MEFs
[(Tet(O)-Flag- hECD-IRESeGFP;rtTA)]

or control MEFs [(Tet(O)-Flag- hECD-

IRESeGFP)] were treated with Dox for 48 h followed by treatment with Thapsigargin. Cell
lysates were prepared at indicated time points and equal amount of proteins was resolved
on SDS-PAGE gel followed by western blot with indicated antibodies
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2.4.7 ECD overexpression protects cells from ER stress-induced cell death
ER stress response is initially aimed at the survival of cells (76); however severe ER stress
shifts the response from a pro-survival to a pro-apoptotic response (36,44) through PERKmediated induction of CHOP expression, a transcription

factor that enhances the

expression of pro-apoptotic pathway genes (37-41,43,44,77). Several studies found that
inhibition of the PERK pathway protected cells against stress-induced cell death (78-81).
Given our observations that ECD functions as a modulator of PERK signaling, we assessed
if the level of ECD determines a differential survival vs. apoptotic cell fate upon ER stress
induction. For that purpose, we treated control MEFs or Dox-inducible ECD
overexpressing MEFs with Thapsigargin and then assessed the level of apoptosis induction
by examining caspase 3 cleavage (82). As anticipated, a Thapsigargin dose-dependent
increase in cleaved caspase 3 levels was observed in control MEFs, whereas the levels of
cleaved caspase 3 were markedly lower in ECD-overexpressing MEFs (Figure 2.14).
Moreover, given the role of stress-activated protein kinases SAPK/JNK in mediating ER
stress-induced cell death, as a downstream target of IRE1α (44,83,84), we further assessed
the levels of phospho-SAPK/JNK. Notably, while the p-SAPK/JNK level increased in
response to Thapsigargin in control MEFs, no changes were observed in ECDoverexpressing MEFs (Figure 2.14, compare lane 1-3 to 4-6).
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Figure 2.14: Decreased cleaved caspase 3 and p-SAPK/JNK levels in ECD
overexpressing MEF upon Thapsigargin. ECD was induced as described in (Fig. 3 and
4) followed by Thapsigargin treatment for 24 h. Equal amount of proteins was resolved on
SDS-PAGE gel followed by western blot with indicated antibodies
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To further assess the pro-survival effects of ECD against apoptotic cell fate upon ER stress
induction, we assessed the abilities of control vs. ECD-overexpressing MEFs to form
colonies after their exposure to ER stress. For this purpose, equal numbers of control or
ECD overexpressing MEFs were treated with Thapsigargin for 24h, and the cells were
maintained in Thapsigargin-free medium for 10 days followed by crystal violet staining
and counting of surviving colonies. Notably, more colonies were observed in ECD
overexpressing MEFs as compared to control MEFs (Figure 2.15), further supporting the
conclusion that ECD provides survival advantage upon ER stress.

83

Dox:
Tg:

+
-

+
50nM

+
100nM

Tet(O)-Flag- hECD
-IRES eGFP

Tet(O)-Flag- hECD
-IRES eGFP; rtTA

1.2

Tet(O)-Flag- hECD
-IRES eGFP

1

Relative survival

**
0.8

Tet(O)-Flag- hECD
-IRES eGFP; rtTA

0.6
0.4
0.2
0

Tg:

-

50 nM

100 nM

Figure 2.15: Increased colony formation in ECD over-expressing MEFs upon
Thapsigargin. After ECD induction, control and ECD inducible MEFs were trypsinized
and equal number of cells (1,000) were plated in triplicates. 8 h later, the cells were
treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed by
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Crystal blue staining (0.5% in 25% Methanol). The color retained after the wash was
dissolved in 10% Acetic acid and the absorbance was read at 590 nm. The graph below
represents the relative absorbance; Mean +/- SD and p-values from 4 independent
experiments are indicated ** p≤0.002.
----------------------------------

2.4.8 ECD co-localizes and associates with PERK, ATF6, IRE1α and GRP78
Given the roles of ECD in modulating ER stress as presented above, we sought to define
the possible mechanism (s). Previously, ECD has been reported to localize, predominantly,
in the cytoplasm with a fast nuclear export, allowing it to shuttle through the nucleus (85).
Given the roles of ECD in attenuating ER stress signaling, particularly PERK, we first
asked whether ECD could also be localizing to the ER or co-localizes with the upstream
mediators of the ER stress signaling, especially as previous works from the lab showed a
peri-nuclear localization for ECD, which is the classic definition of an ER localization.
Therefore, we performed a proximity ligation assay (PLA) to assess the localization of
ECD relative to PERK and GRP78. Known ECD interaction with PIH1D1 component of
the R2TP served as the positive control (55,59). Indeed, ECD and PIH1D1 formed distinct
foci detectable by PLA (Figure 2.15B, red dots). Significantly, PLA signals were also
observed for ECD and GRP78 or ECD and PERK (Figure 2.15 C-D). Negative controls
(IgG) did not show any PLA signal (Figure 2.15 E).
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Figure 2.15: ECD co-localizes with PERK and GRP78. MCF-10A cells were fixed with
3% PFA and stained with indicated antibodies (all antibodies were generated in rabbit
except anti-ECD mouse antibody) followed by species-specific secondary antibodies
linked to complementary DNA probes to allow fluorescent probe-based detection of the
PCR amplification product as distinct foci. Incubation with Proximity Ligation Assay plus
and minus probes, followed by ligation and amplification, was carried out according to the
manufacturer protocol. Red dots indicate interaction. ECD and PIH1D1 served as the
positive control.
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The localization of ECD close to the ER stress signaling mediators prompted us to assess
their association. For that purpose, we carried out immunoprecipitation (IP) of ECD from
lysates from MCF-10A cell followed by western blotting for PERK, GRP78, IRE1α, and
ATF6 antibodies to assess their association. IP of ECD co-immunoprecipitated PIH1D1
(Figure 2.16) as expected based on known interaction of ECD with PIH1D1 (55,59).
Importantly, PERK, GRP78, IRE1α and ATF6 also co-immunoprecipitated with ECD
(Figure 2.16).
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Figure 2.16: ECD associates with PERK, GRP78, IRE1α and ATF6. Lysates from
MCF-10A cells were subjected to IP with anti-ECD antibody overnight followed by
Western blotting with indicated antibodies. ECD and PIH1D1 served as the positive
controls.
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To further asses these results, we carried out a GST pull down experiment by incubating
bacterially purified GST-fused full length ECD, C-terminal and N-terminal deletion
mutants ECD with cell lysate containing overexpressed GRP78, IRE1α, PERK and ATF6
followed by western blot with the respective antibodies; this GST pull down experiment
will help define the domain(s) on ECD required for their association. Known interaction of
full length GST-ECD with RUVBL1/Pontin was used as a positive control (55). As
expected, full length GST-ECD pulled down RUVBL1/Pontin (Figure 2.17). Significantly,
full length ECD interacts with GRP78, IRE1α and ATF6. N-terminal and C-terminal
deletions of ECD abrogated interaction with GRP78 and ATF6 (Figure 2.17) while only
the C-terminal deletion of ECD abrogated interaction with IRE1α (Figure 2.17), suggesting
that both the N and C termini are required for interaction with GRP78 and ATF6 but only
the C-terminus is required for interaction with IRE1α. GST-ECD did not pull down PERK.
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Figure 2.17: Defining the domain (s) on ECD required for interaction. 3µg of
bacterially purified GST fused ECD full length (FL) and its mutants were incubated with
lysates from 293T cells overexpressing GRP78, IRE1α and ATF6 for 3h at 4°. The GST
beads were washed and resolved on SDS-PAGE gel followed by western blot with
indicated antibodies. Pontin and ECD interaction served as a positive control. Below the
blot is the ponceau.
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2.4.9 ECD associates with GRP78 and PERK upon ER stress induction
We further examined the ER stress-related roles of ECD by assessing its association with
PERK and GRP78 upon ER stress induction. For that purpose, we carried out
immunoprecipitation (IP) of ECD from lysates from the MCF-10A cell, treated or left
untreated with Thapsigargin, followed by western blotting for PERK and GRP78
antibodies to assess their association. IP of ECD co-immunoprecipitated PIH1D1 (Figure
2.18A), as expected based on known interaction of ECD with PIH1D1 (55,59).
Importantly, PERK and GRP78 also co-immunoprecipitated with ECD (Figure 2.18A). A
reverse IP of GRP78 also co-immunoprecipitated ECD, with PERK used as a positive
control (Figure 2.18B). Taken together, these results suggest that ECD associates with
PERK and GRP78.
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Figure 2.18: ECD association with PERK and GRP78 upon ER stress induction.
Lysates from MCF-10A cells, treated or left untreated with Thapsigargin, were subjected
to IP with anti-ECD antibody (A) or anti-GRP78 (B) followed by Western blotting with
indicated antibodies. ECD and PIH1D1(A) or GRP78 and PERK (B) served as positive
controls.
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2.4.10 ECD does not modulate enzymatic activity of PERK in vitro
Given that ECD associates with PERK and modulates its signaling, we hypothesized that
ECD could be affecting PERK signaling either directly or indirectly. To test the direct
hypothesis, we assessed the possibility that ECD affects PERK enzymatic activity. We
performed an in vitro kinase assay of PERK with its substrate eIF2α in the presence of an
increasing concentration of pure ECD protein. This experiment showed that eIF2α
phosphorylation did not change in the presence of an increasing concentration of ECD
(Figure 2.19), suggesting that ECD does not directly modulate PERK enzymatic activity.
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Figure 2.19: ECD does not modulate enzymatic activity of PERK toward eIF2α. In
vitro kinase assay of recombinant human GST fused PERK with its substrate eIF2α in the
presence of increasing concentration of pure ECD protein. Proteins were separated by
SDS-PAGE, transferred to PVDF membrane, and phosphate labeling was detected by
autoradiography.
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2.4.11 ECD positively regulates levels of chaperones, predominantly, GRP78 protein
The results above that ECD does not modulate the enzymatic activity of PERK ruled out
the possibility of a direct effect on PERK signaling. Therefore, we examined the next
possibility of an indirect mechanism whereby ECD acts through another protein to
modulate PERK. GRP78 is a repressor of the three arms of the ER stress signaling,
including PERK, of which it is known to bind to the luminal domain to repress its
activation in unstressed cells (13,14). The dissociation of GRP78 from PERK upon ER
stress is key to activation of PERK signaling, but it is also a reversible process, as GRP78
is also known to bind back to PERK to inhibit its signaling when the stress is relieved.
Accordingly, we asked whether ECD could be cooperating with GRP78 to modulate
PERK signaling especially since ECD and GRP78 associate (Figure 2.16-2.18). To
explore that possibility, we first examined the changes in the levels of GRP78 in the
presence and absence of ECD upon ER stress induction. We first exposed the wild-type
MEFs or MEFs with ECD deletion induced by adeno-Cre to Thapsigargin, and then
assessed the levels of GRP78 protein, at various time points, by western blotting. The
levels of GRP78, over time, were reduced in ECD-null MEFs compared to GRP78 levels
in control MEFs (Figure 2.20A, compare lanes 3-5 with 8-10). Likewise, using
physiological stress, a knock down of ECD in Panc-1 cells led to a decrease in GRP78
levels upon glucose starvation (Figure 2.20B, compare lanes 1-5 with lanes 6-10).
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Figure 2.20: ECD deletion or knock down led to a reduced induced levels of GRP78.
(A): Ecd fl/fl MEFs were treated with adenovirus as previously described and then the
cells were treated with Thapsigargin (50 nM); (B): ECD was knocked down by siRNA
(20 nM) in Panc-1 cells followed by exposure to glucose-free media. Cell lysates were
collected at indicated time points followed by western blot with indicated antibodies.
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To further examine these effects, we used a reciprocal approach by overexpressing ECD
and assessing GRP78 protein levels upon ER stress induction. In the presence of
overexpressed ECD, upon induction of ER stress by Thapsigargin treatment, the levels of
GRP78 were robustly elevated (Figure 2.21A). GRP94 and PDI, two other chaperones
with ER stress-related functions, were also increased although not as robustly as GRP78
(Figure 2.21A). Similar results were obtained with Tunicamycin treatment, another ER
stress inducing chemical (Figure 2.21B).
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Figure 2.21: ECD overexpression led to a robust increase in chaperone levels,
predominantly, GRP78. ECD inducible MEFs [(Tet(O)-Flag- hECD-IRESeGFP;rtTA)]
or control MEFs [(Tet(O)-Flag- hECD-IRESeGFP)] were treated with Dox for 48 h
followed by treatment with Thapsigargin (50 nM, A) or Tunicamycin (50 ng/ml, B). Cell
lysates were prepared at indicated time points and equal amount of proteins was resolved
on SDS-PAGE gel followed by western blot with indicated antibodies.
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2.4.12 ECD does not affect GRP78 transcription or mRNA stability
Based on the distinct effect of ECD depletion or overexpression on GRP78 protein levels,
we next examined GRP78 mRNA induction in the presence or absence of ECD. We
carried out qPCR analyses of mRNA isolated from WT or ECD-null MEFs treated with
Thapsigargin. As expected, GRP78 mRNA levels increased in WT MEFs upon
Thapsigargin treatment (Figure 2.22A); however, the levels of GRP78 mRNA induction
in ECD-null MEFs was comparable to that in control MEFs (Figure 2.22A). Similarly,
GRP78 mRNA levels in control vs. ECD overexpressing MEFs treated with Thapsigargin
were comparable (Figure 2.22B). Likewise, we examined the post-transcriptional effect
of ECD on GRP78 mRNA stability by treating cells with Actinomycin D, to inhibit
mRNA synthesis, and collected mRNA at various time points followed by qPCR with
primers against GRP78 mRNA. The rate of decrease of GRP78 mRNA over time is
comparable between ECD depleted or overexpressed cells and their respective controls
(Figure 2.23A-B), suggesting that ECD does not affect GRP78 mRNA stability. Taken
together, these results suggest that ECD does not affect GRP78 mRNA transcription or
post-transcriptionally.
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Figure 2.22: Effect of ECD on GRP78 mRNA induction. Following ECD deletion by
Adeno-CRE infection (A) or ECD overexpression (B) and Thapsigargin treatment, the
levels of GRP78 mRNA were assessed in WT (control) vs. ECD-/- (Cre-adenovirus
treated) or control vs. ECD overexpressing MEFs using qRT-PCR.
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Figure 2.23: Effect of ECD on GRP78 mRNA stability. Following ECD deletion by
Adeno-CRE infection (A) or ECD overexpression (B) and Thapsigargin treatment, the
cells were treated with Actinomycin D and mRNA was collected at indicated time points.
The levels of GRP78 mRNA were assessed in WT (control) vs. ECD-/- (Cre-adenovirus
treated) or control vs. ECD overexpressing MEFs using qRT-PCR.
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2.4.13 ECD enhances GRP78 protein stability and this effect is required for ECD to
attenuate ER stress signaling
The results above showing that ECD does not regulate GRP78 protein at mRNA level
raised a strong possibility that ECD might instead regulate GRP78 at protein level
especially since the two protein associated. To determine whether GRP78 may be less
stable in ECD null cells or more stable in ECD overexpressing cells, we first knocked
down ECD in Panc-1 cells, which have high levels of GRP78, followed by inhibition of
protein synthesis by cycloheximide treatment over various time points and GRP78
protein levels were analyzed by western blot. Significantly, the time dependent decrease
in GRP78 protein levels following cycloheximide treatment was faster in ECD-knocked
down cells compared to their control cells (Figure 2.24A). Next, to examine the
possibility that ECD overexpression is associated with increased GRP78 protein stability,
control or ECD overexpressing cells were treated with Thapsigargin to induce GRP78
protein, followed by cycloheximide (CHX) treatment over various time points. Notably,
the time-dependent decrease in GRP78 levels was slower in ECD overexpressing MEFs
as compared to control MEFs (Figure 2.24B). Finally, to determine whether the increase
in GRP78 protein stability upon ECD overexpression was required for the attenuation of
PERK activation seen upon ER stress induction, we depleted GRP78 using siRNA in
both control and ECD overexpressing MEFs followed by Thapsigargin treatment.
Notably, even in the presence of overexpressed ECD, the attenuating effect of ECD
overexpression on PERK phosphorylation upon Thapsigargin treatment was abrogated by
GRP78 knockdown (Figure 2.24C; compare lane 5-6 with 7-8). Furthermore, this knock
down of GRP78 reduced the survival effect of ECD overexpression by reducing the
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colonies’ ability to form the ECD overexpressing cells (Figure 2.24D, compare lane 2
and 4). Taken together, these results support the conclusion that ECD positively regulates
GRP78 protein level upon ER stress induction to attenuate PERK activation and provide
survival advantage.
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Figure 2.24: ECD mediated GRP78 protein stability is required for ECD ER stress
function. (A): ECD was knocked down in Panc-1 cells followed by cycloheximide
treatment (25 uM). Cell lysates were prepared at indicated time points followed by
western blot with indicated antibodies. (B): ECD inducible MEFs and their control MEFs
were treated with Dox, as described previously, followed by treatment with Thapsigargin
and then Cycloheximide treatment (25 uM) for indicated time points. Cell lysates were
prepared followed by western blotting with indicated antibodies. (C): ECD
overexpressing and their control MEFs were treated with GRP78 SiRNA (30 nM) or
control siRNA (scrambled). 24 h later, the cells were treated with Dox for 48 h to induce
ECD overexpression followed by Thapsigargin treatment (50 nM). Equal amount of
proteins was resolved on SDS-PAGE gel followed by western blotting with indicated
antibodies. (D): After ECD induction, control and ECD inducible MEFs were trypsinized
and equal number of cells (1,000) were plated in triplicates. 8 h later, the cells were
treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed by
crystal blue staining (0.5% in 25% Methanol). The color retained after the wash was
dissolved in 10% Acetic acid and the absorbance was read at 590 nm. The graph below
represents the relative absorbance; Mean +/- SD and p-values from 3 independent
experiments are indicated ** p≤0.002
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2.5 DISCUSSION

The ER-localized stress response pathway referred to as the UPR is a well-conserved
response to a number of cellular stresses such as unfolding of proteins in the ER. The UPR
elicits a spectrum of downstream responses whose outcomes range from restoration of
homeostasis to cellular apoptosis if the stress is extreme and prolonged (36,44). The UPR
thus represents a double-edged sword and must be intricately regulated to prevent
inappropriate cellular outcomes. Mechanisms that help modulate the magnitude and type
of the UPR in response to physiological or pathological stress stimuli are not fully
understood. In this study, we provide evidence that ECD protein is a repressor of stress
response.
Several lines of circumstantial evidence discussed in the Introduction section
suggested a potential involvement of ECD in UPR but direct support for such a role has
been lacking. To explore a connection of ECD to stress response pathways, we first
assessed the effects of multiple stress stimuli on ECD protein levels. Induction of stress
both chemically (Thapsigargin, Tunicamycin, BFA, DTT, sorbitol, and H2O2) and
physiologically (glucose starvation and NOX4 expression) in multiple cell lines led to
downregulation of ECD protein levels (Figure 2.1-2.3). The concomitant increase in ECD
mRNA levels (Figure 2.4) suggests that the protein was transcriptionally induced. By using
AFT6 KO, IRE1α and PERK kinase knockout (KO), we found that PERK is the upstream
mediator of the decrease in ECD protein levels and that in PERK KO MEFs, ECD protein
and mRNA levels did not change upon ER stress induction (Figure 2.5-2.6). Since ECD is
not a substrate for PERK phosphorylation (Figure 2.7) but ECD protein levels did not
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change when eIF2α phosphorylation, the downstream effect of PERK activation, was
disrupted (Figure 2.8), the results strongly suggest that ECD protein levels are regulated
via the PERK-eIF2α axis upon ER stress induction. Since that axis controls translation
upon stress induction, then the results further suggest that ECD protein undergoes a PERKeIF2α-dependent translation block upon ER stress. The decrease in ECD protein levels in
other forms of stress, including oxido-reductive and osmotic stresses, further argues that
induction of stress in general leads to an eIF2α-dependent decrease in ECD protein levels.
In fact, all forms of cellular stress, including viral infection and nutrient limitation in
addition to those mentioned above, converge to a common node, eIF2α. Moreover, they
are interconnected. For instance, viral infection induces ER stress (86) due to the increase
viral protein synthesis. Oxidative stress and nutrient limitation also induce ER stress (8789).
With regard to ER stress, these findings linked ECD to the PERK-eIF2α pathway.
A functional connection of ECD to the PERK arm of the UPR is supported by the distinct
modulation of the PERK-mediated responses elicited by perturbations of the cellular levels
of ECD. Depletion of ECD sensitized cells to PERK signaling in response to Thapsigargin
treatment, with increase in p-PERK and p-eIF2α levels, as well as an increase in the
downstream effector of PERK, the transcription factor CHOP, altogether led to increased
caspase 3 cleavage and reduced survival of these ECD depleted MEFs (Figure 2.10).
Similarly, physiological stress by glucose deprivation in a human pancreatic carcinoma cell
line (Panc-1) upon ECD knock down resulted in increased ER stress with enhanced peIF2α, spliced XBP-1 and cell death (Figure 2.11). Reciprocally, upregulation of ECD
reduced PERK signaling upon induction of ER stress (Figure 2.12). As activation of the
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PERK pathway promotes cell death in response to ER stress, primarily through CHOPdependent expression of pro-apoptotic genes (37-45) and abrogation of PERK signaling
protects cells against stress-induced cell death (78-80), our results supported the likelihood
that ECD functions to modulate PERK pathway activity and promote cell survival during
ER stress. Indeed, assessment of cellular survival in response to ER stress showed that
reduction in ECD levels impaired cell survival to ER stress (Figure 2.10) while
overexpression of ECD promoted cell survival (Figure 2.14).
Collectively, these results support the conclusion that ECD and PERK are linked
through a negative feedback mechanism whereby ECD exerts an inhibitory effect on PERK
pathway signaling and activated PERK in turn reduces ECD protein levels via eIF2αdependent translational block. Consistent with a reciprocal negative feedback relation
between ECD and PERK, activated PERK negatively regulates cell growth (46-48);
conversely, ECD positively regulates cell growth (54) and is overexpressed in human
breast and pancreatic cancer specimens, correlating with poor prognostic markers and
shorter survival (69,90). While the physiological benefit of an increased ECD mRNA upon
ER stress is not yet understood, a speculation is that this effect may reflect a feedback
response to the decrease in ECD protein levels whereby cells may try to compensate for
the loss of ECD but ECD translation is blocked. Although ECD has been reported to play
roles in pre-mRNA splicing in drosophila (91), it is unlikely that ECD alters its own mRNA
splicing upon ER stress because ECD protein levels decrease upon ER stress.
Modulation of ECD levels using knockdown or overexpression demonstrated that
ECD is a positive regulator of GRP78 levels (Figure 2.20 and 2.21). While slight increases
in GRP94 and PDI were observed, the effect on GRP78 was more dramatic. However, this
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effect may be post-translational since ECD did not have a transcriptional or posttranscriptional effect on GRP87 mRNA. The slight increase in GRP94 and PDI, both of
which have ER stress-related functions, further suggests that ECD may affect chaperones’
levels, in general, when overexpressed upon ER stress induction.
As increased expression of GRP78 and other chaperones is known to promote the
clearing of ER stress-causing unfolded protein load and reduce the activation of UPR
sensors (13-15,20), this increase in chaperones levels in the presence of ECD upon ER
stress induction argue that ECD may be repressing stress by elevating chaperone levels.
Indeed, a knock down of GRP78 abrogated the attenuating effect of ECD on PERK
signaling even in the presence of overexpressed ECD (Figure 2.24C). Notably, GRP78 is
required for cell survival not only in response to ER stress (23,92-94) but also in other
stressful and hostile conditions such as glucose deficiency encountered in tumor
microenvironments (95-100). Given that the PERK arm of the UPR is also activated in
cancer (77,101,102) and both ECD and GRP78 are overexpressed in cancer (69,90,95100), we suggest that ECD overexpression may play a similar role to mitigate the negative
consequences of elevated PERK signaling found in cancer. Given the mechanistic link
between ECD and GRP78 in inhibiting the PERK pathway to promote cell survival, it will
be of great interest to explore if GRP78 and ECD are co-overexpressed in tumors that use
the UPR to promote tumor cell survival and hence may be suitable targets for UPR-directed
therapeutic agents.
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ECD protein has been known for many years as an important cell growth regulatory
protein. The overexpression of ECD in cancer, including breast, prostate and pancreatic
cancers, strongly suggests oncogenic roles for ECD. In this study, we presented evidence
for an involvement of ECD in ER stress in cancer. Normal or cancer cell lines with low
levels of ECD exhibited increased ER stress and cell death upon ER stress induction.
Conversely, ECD overexpressing cells exhibited a decreased ER stress and cell death upon
ER stress. Together, these distinct effects of ECD knock down or overexpression on cells
argue that ECD may be functioning as a buffering protein against stress in cells and as a
regulator of sensitivity of cells to ER stress. The increase in ECD mRNA upon ER stress
indicates a transcriptional induction of ECD and further suggests an ER stress-related role.
The functional connection of ECD to the PERK-eIF2α arm of the ER stress signaling
further argues in favor of the pro-survival roles for ECD in stress conditions, since that axis
mediates cell death during ER stress signaling via CHOP induction (1-8). ECD inhibits
PERK-eIF2α signaling while PERK-eIF2α inhibits ECD protein translation, thus
establishing a negative feedback loop between ECD and the PERK arm of the ER stress
signaling.
Mechanistically, ECD may be exerting its effects by multiple ways. Particularly,
the ECD-GRP78 axis is a novel pathway for regulating ER stress. ECD enhances the level
of GRP78, a key chaperone and inhibitor of PERK signaling. As increased expression of
GRP78 and other chaperones is known to promote the clearing of ER stress-causing
unfolded protein load and reduce the activation of UPR sensors (9-12), this increase in
chaperones’ levels in the presence of ECD upon ER stress induction argues that ECD may
be attenuating stress by elevating chaperone levels and enhancing the folding capacity in
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the stressed ER. Indeed, a disruption of the chaperone-enhancing effect of ECD abrogated
the attenuating effect of ECD on PERK signaling even in the presence of overexpressed
ECD. Notably, GRP78 is required for cell survival not only in response to ER stress (1316) but also in other stressful and hostile conditions such as glucose deficiency encountered
in tumor microenvironments (17-22). Given that the PERK arm of the UPR is also activated
in cancer (8,23,24) and both ECD and GRP78 are overexpressed in cancer (17-22,25,26),
we suggest that ECD overexpression may play a similar role to mitigate the negative
consequences of elevated PERK signaling found in cancer. Given the mechanistic link
between ECD and GRP78 in inhibiting the PERK pathway to promote cell survival, it
would be of great interest to explore if GRP78 and ECD are co-overexpressed in tumors
that use the UPR to promote tumor cell survival and hence may be suitable targets for
therapeutic agents directed against ER stress in cancer.

Conclusion:

•

Stress induction by multiple stimuli, Thapsigargin, Tunicamycin, glucose
starvation, H2O2, NOX4 overexpression, DTT, and sorbitol, led to a reduced ECD
protein in multiple cell lines (MCF7, MDA-468, MCF10A, Panc-1, 76NTERT,
MDA231-NOX4).

•

ECD mRNA increased upon Thapsigargin treatment.

•

In PERK KO MREFs, the levels of ECD protein did not change upon ER stress
induction as compared to WT PERK.
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•

In PERK KO MEFs, ECD mRNA levels failed to increase as compared to WT
PERK.

•

PERK does not phosphorylate ECD.

•

The decrease in ECD protein levels is via the PERK-eIF2α axis of the ER stress
signaling.

•

Loss of ECD in cells increased the levels of p-PERK, p-eIF2α, and these effects
were enhanced upon ER stress induction by Thapsigargin treatment or glucose
deprivation along with an increased in CHOP mRNA, and cleaved caspase 3.

•

Loss of ECD slightly increased the levels of spliced XBP-1, the downstream target
of IRE1α but cleaved ATF6 did not significantly change.

•

Loos of ECD correlated with a decrease in the colony formation of ECD-null cells
upon ER stress induction.

•

Overexpression of ECD led to a marked decrease in p-PERK and its downstream
targets, p-eIF2α, ATF4 and CHOP mRNA levels upon ER stress induction

•

Overexpression of ECD upon ER stress induction slightly increased the levels of
spliced XBP1 but ATF6 did not change significantly.

•

Overexpression of ECD upon ER stress induction correlated with a decrease in
caspase 3 cleavage and an increase in the colony formation of ECD overexpressing
cells

•

ECD localized and associated with PERK, ATF6, IRE1α and GRP78.

•

ECD did not modulate enzymatic activity of PERK toward eIF2α.

•

Depletion of ECD upon ER stress induction was associated with decreased GRP78
protein levels.
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•

Overexpression of ECD upon ER stress induction increased the levels of GRP78
protein.

•

GRP78 mRNA was not affected by deletion or overexpression of ECD upon ER
stress induction.

•

Knock down of ECD followed by cycloheximide treatment was associated with a
faster decrease in GRP78 protein level as compared to control cells with intact
cellular ECD levels.

•

ECD overexpression plus cycloheximide treatment correlated with a slower
decrease in GRP78 protein levels.

•

A knock down of GRP78 abrogated the attenuating effect of ECD on PERK, even
in the presence of overexpressed ECD. This effect further correlated with a decrease
in the colony formation of ECD overexpressing cells.
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•

Characterize ER stress elements (ERSE) in ECD gene promoter
The increase in ECD mRNA upon ER stress induction suggests existence of
ERSE in ECD gene promoter. A follow-up study to characterize these ERSE
would be interesting.

•

Assess potential roles of ECD in autophagy through GRP78
In addition to further examining the ECD-GRP78 connection in tumor context, it
would also be interesting to assess whether ECD pro-survival effect upon ER stress
is via GRP78-mediated autophagy. The rationale is that ECD enhanced GRP78
while GRP78 has been implicated in autophagy. Although a clear mechanism was
not presented, it was reported in numerous studies that GRP78 was required for
autophagy induction and that inhibition of GRP78 inhibited autophagy induction
(1-3).

•

Assess potential ECD-R2TP connection in regulating ER stress
The R2TPcomplex, composed of RUVBL1, RUVBL2, PIH1D1 and RPAP3 is a
multi-protein complex which regulates the assembly and stability of many
complexes (4). A study identified a role for RUVBL2 in the regulation of ATF2 in
response to stress through direct interaction with ATF2 (5). ECD is a component
of the R2TP complex (6,7). ECD interacts with the RUVBL1 component of the
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R2TP complex, an interaction required for ECD roles in cell growth (33). It is
reported that knock of RUVBL1 affected cellular level of GRP78 an induced ER
stress (8). Therefore, it would be curious to examine the potential ECD-R2TP
connection in ER stress regulation, especially as ECD overexpression correlated
with enhanced of both GRP78 and RUVBL1 upon ER stress induction (Figure 4.1
below) .

Tet(O)-Flag- hECD
-IRES eGFP; rtTA

Tet(O)-Flag- hECD
-IRES eGFP
Tun:

-

3h

6h

12h

24h

-

3h

6h

12h 24h

ECD

GRP78
RUVBL1
β-actin

Figure 4.1: ECD overexpression correlates with enhancement with RUVBL1 and
GRP78. ECD overexpressing and their control MEFs were treated with Tunicamycin and
protein lysate was prepared at indicated time points followed by western blot with indicated
antibodies.
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•

Assess the requirement of ECD in chaperone (GRP78, GRP94)-mediated ER
calcium regulation. The ER is well known as a site for calcium storage in cells.
ECD regulates the levels of the critical chaperone proteins (GRP78 and GRP94)
that mediate that function of the ER (9,10).

•

Assess the roles of ECD in protein translation through GRP78. GRP78 is
known to be involved in protein translation not only by binding nascent protein in
the ER but importantly by forming the translocation channel in complex with Sec61
(11,12).

•

Explore in vivo studies of the ECD-GRP78 axis in regulating oncogenesisinduced ER stress in mouse models. Works in the lab indicated potential
oncogenic roles of ECD, as its overexpression induced tumors. Tumor initiation
and progression are complex processes characterized by ER stress as a result of the
increased bioenergetics demands in the tumor. Overcoming this early ER stress is
paramount for tumor progression. It would be interesting to assess whether the
ECD-mediated upregulation in the levels of GRP78 is required for tumor initiation
and progression.
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22

ABSTRACT

24

The mammalian Ecdysoneless (ECD) is a highly-conserved ortholog of the Drosophila Ecd gene

25

product whose mutations impair the synthesis of Ecdysone and produce cell-autonomous

26

survival defects but mechanisms by which ECD functions are largely unknown. Here, we present

27

evidence that ECD regulates endoplasmic reticulum (ER) stress response. ER stress induction led

28

to a reduced ECD protein but this effect was not seen in PERK KO or phospho-deficient eIF2α

29

MEFs; moreover, ECD mRNA levels were increased, suggesting impaired ECD translation as

30

the mechanism for reduced protein levels. ECD co-localizes and co-immunoprecipitates with

31

PERK and GRP78. ECD depletion increased the levels of p-PERK, p-eIF2α, and these effects

32

were enhanced upon ER stress induction. Reciprocally, overexpression of ECD led to a marked

33

decrease in p-PERK, p-eIF2α and ATF4 levels, but a robust increase in GRP78 protein levels.

34

However, GRP78 mRNA levels were unchanged, suggesting a post-transcriptional event.

35

Knockdown of GRP78 reversed the attenuating effect of ECD over-expression on PERK

36

signaling. Significantly, overexpression of ECD provided a survival advantage to cells upon ER

37

stress induction. Taken together, we demonstrate that ECD promotes survival upon ER stress by

38

increasing GRP78 protein levels to enhance the adaptive folding protein in the ER to attenuate

39

PERK signaling.

40

2
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INTRODUCTION

42

The endoplasmic reticulum (ER) is a central subcellular organelle with essential roles in the

43

synthesis, folding and maturation of secreted and membrane proteins, biogenesis of cholesterol,

44

calcium homeostasis and regulation of survival and apoptosis pathways (1-10). Aberrations in

45

these ER functions are sensed by well-conserved ER transmembrane sensors, Inositol-Requiring

46

Enzyme 1 alpha (IRE1α), PKR-like ER kinase (PERK) and Activating Transcription Factor 6

47

(ATF6), that activate homeostatic signaling pathways collectively referred to as the unfolded

48

protein response (UPR) (11,12). These ER stress sensors exhibit a dynamic and reversible

49

interaction with the ER chaperone GRP78 (13). In un-stressed cells, GRP78 is bound to luminal

50

domains of UPR sensors, which maintains them in an inactive state (14). During ER stress, the

51

increased load of unfolded proteins competes for GRP78 binding, leading to activation of UPR

52

sensors (15) which, through intermediate signaling, evoke overlapping as well as pathway-

53

specific responses to restore ER homeostasis and promote cell survival or alternatively eliminate

54

stressed cells through apoptosis if homeostasis cannot be restored.

55

The PERK pathway has emerged as a key pathway in cellular UPR response as well as

56

homeostasis under unstressed conditions and in disease states (16-21). Release of GRP78 from

57

PERK leads to its dimerization, auto-phosphorylation and activation (15,22,23). A major PERK

58

substrate is the eukaryotic translation initiation factor 2 alpha (eIF2α) whose phosphorylation by

59

PERK inactivates it leading to a block in general cap-dependent protein translation and

60

consequent decrease in the protein load entering the ER (24); concurrently, PERK signaling

61

selectively enhances the cap-independent translation of specific mRNAs, such as Activating

62

Transcription Factor 4 (ATF4) (24). ATF4 induces the expression of CCAAT/enhancer-binding

63

protein-homologous protein (CHOP) which promotes apoptosis in response to stress (24-32).
3
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PERK-induced phosphorylation of eIF2α also inhibits cell cycle progression by reducing the

65

levels of cyclins and hence cyclin-dependent kinase 2 (CDK2) activity (33-35). Termination of

66

PERK signaling, together with de-phosphorylation of eIF2α, is required to re-initiate protein

67

synthesis and resume cell cycle. Thus, PERK-mediated UPR leads to a coordinated program of

68

cellular protection and mitigation of stress. However, PERK also contributes to an alternate

69

outcome through CHOP-mediated activation of a cellular death pathway to eliminate severely

70

damaged cells (24-32). Mechanisms to fine-tune the outcomes of UPR pathways are important to

71

mitigate the negative consequences of ER stress. This is of particular importance under

72

conditions where cells experience ER stress as part of their physiological responses, such as

73

antibody-secreting plasma cells or insulin-secreting pancreatic islet cells (36). We have identified

74

ECD as a negative regulator of the PERK-mediated UPR.

75

The Ecd gene was first identified based on genetic mutations in Drosophila that lead to reduced

76

production of the developmentally-regulated steroid hormone Ecdysone, which is synthesized in

77

the ER, hence the designation of ecdysoneless for such fly mutants (37). The mammalian Ecd

78

gene was cloned based on the rescue of growth defects in S. cerevisiae mutant in the growth

79

control regulatory gene 2 (GCR2), a glycolysis regulatory gene (38). Thus, ECD was thought to

80

be involved in mammalian glycolysis gene expression and initially named hSGT1 (human

81

suppressor of gcr2)(38). We identified the same gene in a screen for interacting partners of

82

human papilloma virus E6 oncoprotein and found it to interact with p53 and transactivate p53-

83

regulated genes (39,40).

84

To elucidate the functional role(s) of mammalian ECD, we generated Ecd-null mice and

85

demonstrated that homozygous deletion of Ecd was early embryonic lethal while ex vivo Cre-

86

mediated deletion of Ecd in Ecdfl/fl mouse embryonic fibroblasts (MEFs) led to proliferative
4
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block and a significant decrease in cell survival (41,42). ECD was found to be essential for E2F

88

target gene expression by facilitating the dissociation of the retinoblastoma RB protein from

89

E2F and promoting the G1-to-S phase cell cycle progression (41). As a consequence, Ecd-null

90

MEFs showed a decrease in the levels of cyclins A, B1, E and D1, reduction in CDK2 kinase

91

activity and were arrested in G1 phase of the cell cycle (41). Interestingly, E2F family proteins

92

such as the E2F1 have been implicated in UPR-mediated cell death (43). In addition to its

93

promotion of the G1/S phase, ECD also promotes G2/M phase of the cell cycle and its

94

knockdown induced not just a G2/M arrest but also apoptosis (44). Induction of UPR not only

95

induces apoptosis but also halts cell cycle progression in G1 and G2 phases (33-35,45) and these

96

effects are mediated by PERK (33,34), suggesting a potential connection between ECD and the

97

PERK arm of the UPR.

98

More recently, we uncovered another mechanism by which ECD regulates cellular proliferation,

99

involving its interaction with RUVBL1 and PIH1D1 components of the prefoldin co-chaperone

100

R2TP (42) which is involved in the assembly or remodeling of a number of protein and protein-

101

RNA complexes to regulate many physiological processes (46-52). Recently, it was reported that

102

knock down of the RUVBL1 component of the R2TP complex induced cell cycle block and ER

103

stress (53). Furthermore, ECD has been shown to associate with the stress response protein

104

Thioredoxin-Interacting Protein (TXNIP) (54) which is known to bind to the ER chaperone PDI

105

(protein disulfide bond isomerase) to increase its enzymatic activity to relieve ER stress (55).

106

Lastly, TXNIP was recently shown to be a novel component of the UPR and is regulated by the

107

PERK pathway (56). Thus, multiple lines of suggestive evidence pointed to a potential role of

108

ECD in the regulation of ER stress. In this study, we demonstrate that induction of ER stress,

109

using both chemical ER stress inducers (Thapsigargin and Tunicamycin) and physiological ER
5
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stress inducers (glucose starvation), led to a reduced ECD protein, and this effect was not seen in

111

PERK KO or phospho-deficient eIF2α MEFs. Notably, ECD mRNA levels were increased,

112

suggesting impaired ECD translation as a mechanism for reduced protein levels. Moreover, ECD

113

localizes and co-immunoprecipitates with the unfolded protein response mediators PERK and

114

GRP78. While ECD depletion increased the levels of p-PERK and its downstream targets, p-

115

eIF2α and ATF4, ECD overexpression markedly decreased their levels upon ER stress induction,

116

whereas induction of GRP78 protein robustly increased, suggesting an enhanced adaptive folding

117

capacity of the ER. Knockdown of GRP78 reversed the attenuation of PERK signaling seen upon

118

ECD overexpression. Significantly, ECD over-expression and depletion distinctly affected the

119

survival outcome of cells upon ER stress.

120
121

MATERIALS AND METHODS

122

Reagents and antibodies- Thapsigargin, (Cat# 12758) and Tunicamycin (Cat# 12819) were

123

from Cell Signaling, dissolved in DMSO and used at indicated concentrations. SiRNA against

124

GRP78 was from Santa Cruz (Sc-35522) and Cycloheximide was purchased from Sigma (cat#

125

7698). A monoclonal antibody against ECD, generated in our laboratory, has been described

126

previously (57). Antibodies against p-PERK (cat# 3179), ATF4 (cat# 11815), p-eIF2α (cat#

127

9721), eIF2α (cat# 9722), GRP78 (cat# 3177), Caspase 3 (cat# 9662), GRP94 (cat# 2104), s-

128

XBP1 (cat# 12782), RCAS1 (cat# 6960), PDI (cat# 3501) and total PERK (cat# 3192) were from

129

Cell signaling. ATF6 and SERCA2 antibodies were purchased from Enzo Life (cat# ALX-804-

130

381-C100) and abcam (ab2861), respectively. PERK and GRP78 used for immunofluorescence

131

and proximity ligation assay (PLA) were from Santa Cruz (cat# sc-9477) and abcam (ab21685),

6
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132

respectively. PIH1D1 was from Santa Cruz (18Y9 sc-101000). GRP78 for IP/WB was purchased

133

from abcam (cat#21685).

135

Establishment of MEFs with doxycycline-inducible ECD over-expression from Ecd transgenic

136

mice- MEFs were generated from 13.5 days old embryos of mice of the genotype Tet(O)-Flag-

137

hEcd-IRES-eGFP used as control. rtTA was introduced retrovirally to generate Tet(O)-Flag-

138

hEcd-IRES-eGFP; rtTA (the derivation of the transgenic mice will be described separately).

139
140

Cell lines and culture conditions- Ecd

fl/fl

MEFs were maintained in DMEM medium

141

supplemented with 10% fetal bovine serum and treated with adenoviruses coding for GFP

142

(adeno-GFP, control) or Cre (adeno-Cre) as described previously (41,42). Panc-1 cells have been

143

previously described (58). For ECD overexpression studies, control MEFs or ECD over-

144

expressing MEFs were cultured with 1μg/ml of Doxycycline (Cat # 231286, BD Biosciences) to

145

induce expression of the Ecd transgene. MEFs with a non-phosphorylatable eIF2α were obtained

146

from Dr. Thomas Rutkowski’s lab, Carver College of Medicine, Iowa and has been described

147

elsewhere (59). PERK knockout (KO) MEFs were from ATCC (CRL-2976). Immortal human

148

mammary epithelial cell line MCF-10A was cultured in DFCI-1 medium (42).

149
150

Cellular Fractionation and Immunoprecipitation- Subcellular fractionation of MCF-10A cells

151

into soluble (GAPDH was used as a marker(42,60)) and microsomal fractions (PERK and

152

SERCA2 were used as a marker) was carried out according to the manufacturer protocol (Sigma

7
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Aldrich, Cat# ER0100)(61). For immunoprecipitation (I.P), cells were washed in Phosphate

154

Buffered Saline (PBS) and lysed in CHAPS buffer [(0.3% CHAPS, 20 mM Tris-HCl (pH 7.4),

155

120 mM NaCl, 10% glycerol, 5 mM EDTA supplemented with protease and phosphatase

156

inhibitor (Roche, Cat# 04906837001 and 11836145001)].

157
158

Western blotting- For western blotting, cell lysates were prepared in RIPA buffer (Cat# 89901,

159

Thermo Scientific) supplemented with protease inhibitors (Roche, Cat# 11836145001). Lysates

160

were resolved on SDS-PAGE gel, transferred on to nylon membrane (IPVH00010, Millipore),

161

and subjected to ECL-based Western blotting as described (41,42).

162
163

Immunofluorescence analysis- Immortal MEFs were cultured on coverslips, fixed for 30 min in

164

3% Paraformaldehyde (PFA) and permeabilized in PBS (containing 0.5 % Triton X-100 and

165

10% goat serum) for 20 min at room temperature, followed by blocking in PBS (containing 10%

166

goat serum) for 1 hour at room temperature. The cells were then incubated with primary

167

antibodies in blocking buffer overnight at 4°C followed by 1-hour incubation with their

168

corresponding secondary antibodies in blocking buffer at room temperature. Cells were then

169

washed in PBS (containing 0.1% Tween-20) and then mounted for confocal with the super-

170

resolution structure-illuminated microscopy (SIM). Confocal images were obtained using the

171

Carl Zeiss LSM 510 microscope and 3D-SIM images were collected with a Zeiss ELYRA PS.1

172

illumination system (Carl Zeiss).

173

8

Downloaded from http://mcb.asm.org/ on June 29, 2017 by UNIV OF NEBRASKA MED CTR

153

Proximity Ligation Assay (PLA)- PLA was previously described (62). Briefly, MCF-10A cells

175

were fixed with 3% PFA, stained with the indicated antibodies and incubated with Proximity

176

Ligation Assay plus and minus probes followed by ligation and amplification reaction according

177

to the manufacturer’s protocol (DuoLink Sigma).

178
179

Colony Formation Assay- For clonogenic assay, 1,000 cells were plated in triplicate and allowed

180

to attach to the plate (about 8 h) followed by treatment with Thapsigargin for 24h. 10 days later,

181

colony formation was assessed as previously described (41,42).

182
183

RNA isolation and real-time quantitative PCR (qRT-PCR)- Total RNA was isolated using the

184

TRizol reagent (Invitrogen cat# 15596018). 1 µg of RNA was reverse- transcribed using

185

SuperScript TMII reverse transcriptase (Invitrogen cat# 18064014). The qPCR was performed

186

with primer sets indicated in the table:
Primers used for the Real-time quantitative PCR

Genes

Forward primer

Reverse primer

mouse CHOP

CTGCCTTTCACCTTGGAGAC

CGTTTCCTGGGGATGAGATA

human CHOP

CATTGCCTTTCTCCTTCGGG

CCAGAGAAGCAGGGTCAAGA

mouse GRP78

AGTGGTGGCCACTAATGGAG

CAATCCTTGCTTGATGCTGA

mouse Ecd

CCGGTCTGGCACAAACTTCTGCTG

AGGGTCGAAGCATCCCTCCATCGA

human Ecd

ACTTTGAAACACACGAACCTGGCG TGATGCAGGTGTGTGCTAGTTCCT

187

9
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188

Induction of ER stress by glucose starvation- Panc-1 cells were maintained in DMEM

190

supplemented with 10% fetal bovine serum and then switched to glucose-free DMEM medium

191

(cat# 11966-025, life technologies) for indicated times.

192
193

Statistical analysis- for assessment of statistical significance, a Student t test was used. P values

194

of < 0.05 were considered statistically significant.

195
196
197

RESULTS

198

Induction of ER stress leads to reduced ECD protein expression in a PERK-eIF2α-dependent

199

manner- To begin to explore the potential link of ECD to ER stress, we asked if the levels of

200

ECD protein are affected by induction of ER stress. For this purpose, immortal human mammary

201

epithelial cell line MCF-10A was treated with Thapsigargin or Tunicamycin, two commonly

202

used chemical ER stress inducers (63), and ECD protein levels were analyzed by western

203

blotting. Treatment with both ER stress inducers increased the level of p-eIF2α as expected (63)

204

(Fig. 1A&B). Notably, a concomitant time-dependent decrease in ECD protein levels was

205

observed upon treatment with either Thapsigargin (Fig. 1A) or Tunicamycin (Fig. 1B).

206

Given the effect of chemical ER stress inducers on ECD protein levels, we next assessed whether

207

physiological stress such as glucose starvation would have similar effects. For this purpose, we

208

used human pancreatic carcinoma cell line (Panc-1) which is known to exhibit ER stress upon

209

glucose starvation (63). Significantly, similar to chemical ER stress, glucose starvation-induced
10
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ER stress also exhibited a reduced levels of ECD protein(Fig. 1C). To assess whether the

211

decrease in ECD protein levels was due to reduced ECD mRNA levels, we measured ECD

212

mRNA levels using qRT-PCR. Induction of CHOP mRNA was used as a control (Fig. 1D).

213

Notably, ECD mRNA levels were not only not reduced but in fact showed an increase (Fig. 1E),

214

suggesting that the reduction in ECD protein level was not at the transcriptional level; likewise,

215

physiological stress by glucose starvation also increased ECD mRNA levels (Fig. 1F). Since

216

PERK activation and subsequent phosphorylation of eIF2α mediates translational block in

217

response to ER stress (24), we used MEFs in which this pathway is genetically abrogated. First,

218

we treated Wild-Type (WT) MEFs or MEFs from PERK kinase domain knockout (PERK-KO)

219

mice (64) with Thapsigargin and analyzed ECD protein levels by western blotting. The expected

220

lack of PERK pathway activation in PERK-KO MEFs was confirmed by lack of induction of

221

PERK phosphorylation in PERK-KO MEFs compared to WT MEFs (Fig.1G). Significantly,

222

while a decrease in ECD protein levels was observed in WT MEFs treated with Thapsigargin, the

223

levels of ECD protein were unchanged in PERK-KO MEFs (Fig. 1G). Then, ECD mRNA were

224

assessed in PERK KO and control MEFs to determine whether the levels are altered upon

225

Thapsigargin treatment. Again, CHOP mRNA induction was used as a positive control (Fig. 1H).

226

As expected, in PERK KO MEFs, CHOP mRNA is very minimally induced upon Thapsigargin

227

treatment as compared to control cells (Fig. 1H), since CHOP is downstream of PERK (24-32).

228

Notably, while ECD mRNA increased in control WT MEFs, in PERK KO MEFs, induction of

229

ECD mRNA is low as compared to control WT PERK MEFs (Fig. 1I).

230

To further examine the role of the PERK pathway in the downregulation of ECD protein

231

expression, we utilized MEFs from mice that carry a serine 51 to alanine mutation in eIF2α

232

which prevents its phosphorylation by activated PERK and makes the cells resistant to PERK11
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mediated translation block upon ER stress induction (59). As expected, the levels of p-eIF2α

234

increased in WT MEFs but not in the phospho-deficient eIF2α mutant MEFs when ER stress was

235

induced with Thapsigargin or Tunicamycin (Fig. 1J, compare lanes 1-3 with lanes 4-6).

236

Importantly, while ECD protein levels decreased in WT MEFs treated with ER stress inducers

237

(Fig. 1J, compare lane 1 to lanes 2-3), the levels of ECD protein did not change in identically-

238

treated mutant eIF2α MEFs (Fig. 1J compare lane 4 to lanes 5-6). Together, these results support

239

a conclusion that ECD protein levels are downregulated upon ER stress in a PERK-eIF2α

240

dependent manner, and that ER stress upregulates ECD mRNA levels, suggesting a regulatory

241

link between ECD and the PERK pathway of ER stress.

242
243

ECD co-localizes and associates with PERK and GRP78- To further explore a potential link

244

between ECD and the ER stress pathway, we assessed the localization of ECD. We first

245

performed immunofluorescence using Super-resolution Structured Illumination Microscopy

246

(SIM), a technique that offers a much higher resolution than conventional confocal microscopy

247

(65,66). Co-localization of PERK and GRP78 served as a positive control since PERK and

248

GRP78 are known interacting partners (13). Indeed, we observed that endogenous PERK and

249

GRP78 were co-localized in a punctate distribution (Fig. 2A). Significantly, ECD also co-

250

localized with PERK and GRP78 (Fig. 2B & C), although not as extensive as GRP78-PERK co-

251

localization. Negative controls rabbit and mouse IgGs showed no staining (Fig. 2 D & E). Next,

252

we performed sub-cellular fractionation of MCF-10A cells to biochemically assess the ER

253

localization of ECD. This analysis showed expected presence of ECD in the soluble fraction

254

(40,42). Importantly, ECD was prominently present in the ER-containing microsomal fraction

255

(Fig. 2F). Given the co-localization of ECD with PERK and GRP78 (Fig. 2A-C), we assessed if
12
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ECD associates with PERK and/or GRP78. First, we used PLA to assess the proximity of ECD

257

relative to GRP78 and PERK in MCF-10A cells. Known ECD interaction with

258

PIH1D1component of the R2TP served as positive control (42,46). Indeed, ECD and PIH1D1

259

formed distinct foci detectable by PLA (Fig. 2G, red dots). Significantly, PLA signals were also

260

observed for ECD and GRP78 or ECD and PERK (Fig. 2H-I). Finally, we carried out

261

immunoprecipitation (IP) of ECD from lysates from MCF-10A cell, treated or left untreated with

262

Thapsigargin, followed by western blotting for PERK and GRP78 antibodies to assess their

263

association. IP of ECD co-immunoprecipitated PIH1D1 (Fig. 2K), as expected based on known

264

interaction of ECD with PIH1D1 (42,46). Importantly, PERK and GRP78 also co-

265

immunoprecipitated with ECD (Fig. 2K, left panel). A reverse IP of GRP78 also co-

266

immunoprecipitated ECD, with PERK used as a positive control (Fig. 2K right panel). Taken

267

together, these results suggest that ECD associates with PERK and GRP78.

268
269

ECD regulates the PERK arm of the UPR- The association of ECD with PERK and GRP78

270

(Fig. 2) and abrogation of the decrease in ECD levels in PERK KO cells upon ER stress (Fig.1)

271

suggested that ECD may be functionally linked to UPR through PERK pathway. Therefore, we

272

assessed the activation of the PERK pathway in the absence or presence of UPR inducers in cells

273

in which ECD could be inducibly deleted. For this purpose, we utilized Ecdfl/fl MEFs which have

274

been previously established and shown to exhibit Ecd gene deletion and loss of ECD protein

275

expression upon infection with adenovirus expressing Cre recombinase (41). Previously, we

276

have observed that induction of Ecd deletion in these Ecdfl/fl MEFs, aside from inducing cell

277

cycle arrest, led to a decrease in cell survival even in the absence of any stress (41,42).

13

Downloaded from http://mcb.asm.org/ on June 29, 2017 by UNIV OF NEBRASKA MED CTR

256

Notably, Cre-meditated deletion of Ecd in the Ecdfl/fl MEFs led to an increase in the levels of

279

phospho-PERK (p-PERK) and p-eIF2α, when compared to control adeno-GFP infected MEFs

280

(Fig. 3A, compare lane 1 with 3), and these effects were further enhanced by treatment with

281

Thapsigargin (Tg), the inhibitor of the Sarco/Endoplasmic Reticulum Calcium ATPase (Fig. 3A,

282

compare lane 2 with 4). Spliced XBP1 also showed some increase in ECD null cells upon

283

Thapsigargin treatment while ATF6 did not show a significant change (Fig. 3A). Consistent with

284

the increased p-PERK levels upon ECD deletion, Thapsigargin treated ECD-depleted MEFs also

285

exhibited increased expression of CHOP mRNA (Fig. 3B), a downstream effector of the PERK

286

pathway whose target genes promote cell death (24-28,30,31). The increased CHOP mRNA

287

correlated with an increased cleaved caspases 3 in ECD null cells (Fig. 3C, compare lane 2 with

288

4) and a significant reduction in cell survival, as measured by colony-forming assays (Fig. 3D).

289

To further assess these effects, we used physiological stress in Panc-1 cells (Fig. 3E) in which

290

ECD was knocked down followed by glucose starvation. Again, here too, a siRNA knock down

291

of ECD plus glucose starvation led to an enhanced eIF2α phosphorylation, the downstream target

292

of PERK, and increased cleaved caspase 3 as compared to control cells (Fig. 3E, compare lanes

293

1-5 with lanes 6-10), suggesting more cell death in ECD-knocked down cells upon glucose

294

starvation.

295

In a reciprocal approach, we overexpressed ECD and then examined its impact on the UPR, in

296

particular the PERK pathway, upon ER stress induction. To this end, we generated MEFs from

297

mice that carry a Doxycycline (Dox)-inducible Ecd transgene ((Tet(O)-Flag-hECD-IRES-eGFP;

298

rtTA)) or a control transgenic mouse without rtTA ((Tet(O)-Flag- hECD-IRESeGFP)). These

299

MEFs were treated with Dox to induce ECD overexpression, followed by treatment with

300

Thapsigargin. As expected, control MEFs exhibited an increase in p-PERK and CHOP mRNA;
14
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however, the MEFs with Dox-induced ECD overexpression exhibited a substantially reduced

302

level of p-PERK and CHOP mRNA upon Thapsigargin treatment as compared to control MEFs

303

(Fig. 3F & G). Likewise, when the MEF cell lines were treated with Thapsigargin for various

304

time points (3, 6, 12 or 24h), ECD over-expressing MEFs exhibited lower levels of p-PERK

305

compared to those in control MEFs (Fig. 3H, compare lanes 1-5 with lanes 6-10).

306

corresponding reduction in the levels of ATF4, a downstream target of PERK signaling, was

307

seen in ECD over-expressing MEFs compared to their control MEFs (Fig. 3H, compare lanes 3-5

308

with lanes 8-10); s-XBP1 and ATF6 also were slightly reduced in ECD over-expressing MEFs

309

(Fig. 3H, compare lanes 1-5 with lanes 6-10). Importantly, ECD overexpression was associated

310

with a substantially higher level of GRP78 following Thapsigargin treatment as compared to

311

control MEFs (Fig. 3H compare lanes 2-5 to lanes 7-10); GRP94 protein and PDI, two other

312

chaperones, were also slightly increased in ECD over-expressing MEFs but not as dramatically

313

increased as GRP78 upon Thapsigargin treatment (Fig. 3H compare lanes 1-5 to lanes 6-10).

314

Similar to Thapsigargin, induction of ER stress with Tunicamycin, which induces ER stress by

315

inhibiting glycosylation of proteins in the ER, was also associated with lower levels of p-PERK

316

and p-eIF2α in ECD overexpressing MEFs as compared to control MEFs (Fig. 3I compare lanes

317

2-5 with lanes 7-10). Furthermore, higher levels of GRP78 protein was also observed in ECD

318

overexpressing MEFs as compared to control MEFs upon Tunicamycin treatment (Fig. 3I

319

compare lanes 2-5 with lanes 7-10). Taken together, these results strongly support a conclusion

320

that ECD negatively regulates PERK signaling while enhancing the adaptive capacity of the cells

321

by increasing levels of chaperones, predominantly, GRP78 protein in response to ER stress.

322

The increased induction of GRP78 is required for ECD to attenuate PERK signaling-

323

Induction of GRP78 expression during ER stress is a homeostatic mechanism to reduce the
15
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unfolded protein load in the ER, thereby reducing the activation of UPR sensors. As a major

325

regulator of PERK, overexpression of GRP78 has been shown to reduce PERK signaling upon

326

ER stress induction (13). Given the enhanced induction of GRP78, together with attenuation of

327

PERK signaling in ECD overexpressing MEFs exposed to ER stress (Fig. 3H-I), we examined

328

the possibility that the increased GRP78 levels upon ECD overexpression may be

329

mechanistically linked to the reduction of PERK signaling. To investigate this possibility, we

330

first examined changes in the levels of GRP78 in ECD deleted MEFs where we observed

331

increased PERK phosphorylation (Fig. 3A). To assess if ECD was required for optimal GRP78

332

protein levels upon ER stress, we exposed the wild-type MEFs or MEFs with Ecd deletion

333

induced by adeno-Cre (as in Fig. 3A-D) to Thapsigargin, and then assessed the levels of GRP78

334

protein, at various time points, by western blotting. The levels of GRP78, over time, were

335

reduced in ECD-null MEFs compared to GRP78 levels in control MEFs (Fig. 4A, compare lanes

336

3-5 with 8-10). Likewise, using physiological stress, a knock down of ECD in Panc-1 cells led to

337

a decrease in GRP78 levels upon glucose starvation (Fig. 4B, compare lanes 1-5 with lanes 6-

338

10). To examine whether the reduced induction of GRP78 in ECD-null MEFs was a result of

339

reduced GRP78 mRNA expression, we carried out qPCR analyses of mRNA isolated from WT

340

or Ecd-null MEFs treated with Thapsigargin. As expected, GRP78 mRNA levels increased in

341

WT MEFs upon Thapsigargin treatment (Fig. 4C); however, the levels of GRP78 mRNA

342

induction in Ecd-null MEFs was comparable to that in control MEFs (Fig. 4C). Similarly,

343

GRP78 mRNA levels in control vs. ECD over-expressing MEFs treated with Thapsigargin were

344

comparable (Fig. 4D). To determine whether GRP78 may be less stable in ECD null cells, we

345

first knocked down ECD in Panc-1 cells, which have high level of GRP78, followed by

346

inhibition of protein synthesis by cycloheximide treatment over various time points and GRP78

16
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protein levels were analyzed by western blot. Significantly, the time dependent decrease in

348

GRP78 protein levels following cycloheximide treatment was faster in ECD-knocked down cells

349

compared to their control cells (Fig. 4E). Next, to examine the possibility that ECD

350

overexpression is associated with increased GRP78 protein stability, control or ECD over-

351

expressing cells were treated with Thapsigargin to induce GRP78 protein, followed by

352

cycloheximide (CHX) treatment over various time points. Notably, the time-dependent decrease

353

in GRP78 levels was slower in ECD over-expressing MEFs as compared to control MEFs (Fig.

354

4F). Finally, to determine whether the increase in GRP78 protein levels upon ECD

355

overexpression was required for the attenuation of PERK activation seen upon ER stress

356

induction, we depleted GRP78 using siRNA in both control and ECD overexpressing MEFs

357

followed by Thapsigargin treatment. Notably, the attenuating effect of ECD overexpression on

358

PERK phosphorylation upon Thapsigargin treatment was abrogated by GRP78 knockdown (Fig.

359

4G; compare lane 5-6 with 7-8). Taken together, these results support the conclusion that ECD

360

positively regulates GRP78 protein level upon ER stress induction to attenuate PERK activation.

361
362

ECD overexpression protects cells from ER stress-induced cell death- ER stress response is

363

initially aimed at the survival of cells (67); however severe ER stress shifts the response from a

364

pro-survival to a pro-apoptotic response (23,31) through PERK-mediated induction of CHOP

365

expression, a transcription factor that enhances the expression of pro-apoptotic pathway genes

366

(24-28,30,31,68). Several studies found that inhibition/attenuation of the PERK pathway

367

protected cells against stress-induced cell death (69-72). Given our observations that ECD

368

functions as a modulator of PERK signaling, we assessed if the levels of ECD determine a

369

differential survival vs. apoptotic cell fate upon ER stress induction. For that purpose, we treated
17
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control MEFs or Dox-inducible ECD overexpressing MEFs with Thapsigargin and then assessed

371

the level of apoptosis induction by examining caspase 3 cleavage (73). As anticipated, a

372

Thapsigargin dose-dependent increase in cleaved caspase 3 levels was observed in control

373

MEFs, whereas the levels of cleaved caspase 3 were markedly lower in ECD-overexpressing

374

MEFs (Fig. 5A). Real-time qPCR analyses demonstrated that Thapsigargin-induced expression

375

of CHOP, a PERK-regulated mediator of cell death (24-28,30-32), was lower in ECD

376

overexpressing MEFs as compared to control MEFs (Fig. 5B). To further assess the pro-survival

377

effects of ECD against apoptotic cell fate upon ER stress induction, we assessed the abilities of

378

control vs. ECD-overexpressing MEFs to form colonies after their exposure to ER stress. For this

379

purpose, equal numbers of control or ECD overexpressing MEFs were treated with Thapsigargin

380

for 24h, and the cells were maintained in Thapsigargin-free medium for 10 days followed by

381

crystal violet staining and counting of surviving colonies. Notably, more colonies were observed

382

in ECD overexpressing MEFs as compared to control MEFs (Fig. 5C), further supporting the

383

conclusion that ECD provides survival advantage upon ER stress.

384
385

DISCUSSION

386

The ER-localized stress response pathway referred to as the UPR is a well-conserved

387

response to a number of cellular stresses such as unfolding of proteins in the ER. The UPR elicits

388

a spectrum of downstream responses whose outcomes range from restoration of homeostasis to

389

cellular apoptosis if the stress is extreme and prolonged (23,31). The UPR thus represents a

390

double-edged sword and must be intricately regulated to prevent inappropriate cellular outcomes.

391

Mechanisms that help modulate the magnitude and type of the UPR in response to physiological

18
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392

or pathological stress stimuli are not fully understood. In this study, we provide evidence that

393

ECD protein is a negative regulator of the PERK arm of the UPR through GRP78.
Several lines of circumstantial evidence discussed in the Introduction section suggested a

395

potential involvement of ECD in UPR but direct support for such a role has been lacking. We

396

established that induction of ER stress, using both chemical ER stress inducers (Thapsigargin

397

and Tunicamycin) and physiological ER stressors (glucose starvation), leads to downregulation

398

of ECD protein levels while the mRNA levels were elevated (Fig. 1A-F). By using PERK kinase

399

knockout (KO) or phosphorylation-deficient eIF2α MEFs (Fig. 1G-J), we established that ECD

400

was linked to the PERK pathway of the UPR. The association of ECD with PERK and GRP78

401

(Fig. 2) further linked ECD to the PERK arm of the UPR. A functional connection of ECD to the

402

PERK arm of the UPR is supported by the distinct modulation of the PERK-mediated responses

403

elicited by perturbations of the cellular levels of ECD. Depletion of ECD sensitized cells to

404

PERK signaling in response to ER stress, with increase in p-PERK and p-eIF2α levels, as well as

405

an increase in the downstream effector of PERK, the transcription factor CHOP, leading to a

406

reduced survival of these ECD depleted MEFs (Fig. 3A-E). Reciprocally, upregulation of ECD

407

reduced PERK signaling upon induction of ER stress (Fig. 3F-I). As activation of the PERK

408

pathway promotes cell death in response to ER stress, primarily through CHOP-dependent

409

expression of pro-apoptotic genes (24-32) and abrogation of PERK signaling protects cells

410

against stress-induced cell death (69-71), our results supported the likelihood that ECD functions

411

to modulate PERK pathway activity and promote cell survival during ER stress. Indeed,

412

assessment of cellular survival in response to ER stress showed that reduction in ECD levels

413

impaired cell survival to ER stress (Fig. 3C-E) while overexpression of ECD promoted cell

414

survival (Fig. 5). Collectively, these results support the conclusion that ECD and PERK are
19
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linked through a negative feedback mechanism whereby ECD exerts an inhibitory effect on

416

PERK pathway signaling whereas activated PERK in turn reduces ECD protein levels via eIF2α-

417

dependent translational block. Consistent with a reciprocal negative feedback relation between

418

ECD and PERK, activated PERK negatively regulates cell growth (33-35); conversely, ECD

419

positively regulates cell growth (41) and is overexpressed in human breast and pancreatic cancer

420

specimens, correlating with poor prognostic markers and shorter survival (57,74). While the

421

physiological benefit of an increased ECD mRNA upon ER stress is not yet understood, a

422

speculation is that this effect may reflect a feedback response to the decrease in ECD protein

423

levels to compensate for the loss of ECD but ECD translation is blocked. Although ECD has

424

been reported to play roles in pre-mRNA splicing in drosophila (75), it is unlikely that ECD

425

alters its own mRNA splicing upon ER stress because ECD protein levels decrease upon ER

426

stress.

427

Modulation of ECD levels using knockdown or overexpression demonstrated that ECD is

428

a positive regulator of GRP78 levels (Fig. 3H-I; Fig 4.). While slight increases in GRP94 and

429

PDI were observed, the effect on GRP78 was more dramatic. As increased expression of GRP78

430

and other chaperones is known to promote the clearing of ER stress-causing unfolded protein

431

load and reduce the activation of UPR sensors (13-15,55), we surmised that upregulation of

432

GRP78 and other chaperones (Fig. 3H) may represent one potential mechanism by which ECD

433

negatively regulates the PERK pathway activation and relieves ER stress. Indeed, knockdown of

434

GRP78 eliminated the ability of overexpressed ECD to attenuate PERK pathway signaling (Fig.

435

4G). Notably, GRP78 is required for cell survival not only in response to ER stress (76-79) but

436

also in other stressful and hostile conditions such as glucose deficiency encountered in tumor

437

microenvironment (80-85). Given that the PERK arm of the UPR is also activated in cancer
20
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(68,86,87) and both ECD and GRP78 are overexpressed in cancer (57,74,80-85), we suggest that

439

ECD overexpression may play a similar role to mitigate the negative consequences of elevated

440

PERK signaling found in cancer. Given the mechanistic link between ECD and GRP78 in

441

inhibiting the PERK pathway to promote cell survival, it will be of great interest to explore if

442

GRP78 and ECD are co-overexpressed in tumors that use the UPR to promote tumor cell

443

survival and hence may be suitable targets for UPR-directed therapeutic agents.

444
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Figure Legends:
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Figure 1. Induction of ER stress leads to reduced ECD protein expression in a PERK-

459

eIF2α-dependent manner. (A-C): MCF-10A cells were treated with Thapsigargin (50 nM, A)

460

or Tunicamycin (50 ng/ml, B); Panc-1 (C) were cultured in glucose-free medium and then cell

461

lysates were prepared at the indicated time points. Equal amount of proteins was resolved on

462

SDS-PAGE followed by western blotting with indicated antibodies. Increase in the levels of p-

463

eIF2α served as marker for induction of ER stress. (D-F): MCF-10A cells were treated with

464

Thapsigargin (D-E) and Panc-1 cells were cultured in glucose-free medium (F), then total RNA

465

was isolated followed by qRT-PCR using CHOP primers and ECD primer (Mean +/- SD and p-

466

values are shown from 3 independent experiments * p<0.05). CHOP mRNA induction served as

467

control for Thapsigargin-induced ER stress. (G): Wild-type (WT) PERK and PERK kinase

468

domain knockout (PERK-KO) MEFs were treated with Thapsigargin (50 nM) for 14 h and then

469

cell lysates were resolved on SDS-PAGE gels followed by western blot with indicated

470

antibodies. (H-I): PERK KO and control WT MEFs were treated with Thapsigargin and total

471

RNA was isolated at indicated time points followed by qRT-PCR with primers against CHOP

472

(Fig. H) or ECD (Fig. I). (J): WT eIF2α MEFs or mutant eIF2α phospho-deficient MEFs were

473

treated with Thapsigargin (Tg, 50 nM) or Tunicamycin (Tun, 50 ng/ml) for 14 h and then cell

474

lysates were analyzed by western blotting with indicated antibodies.

475
476

Figure 2: ECD co-localizes and associates with PERK and GRP78. (A-E): Immortal MEFs

477

were fixed in 3% paraformaldehyde (PFA) and stained with indicated antibodies and mounted

478

for analyses with structure-illuminated microscopy (SIM). PERK and GRP78 co-localization

479

served as positive control. DAPI was used to stain the nucleus. (F): MCF-10A cells were

480

fractionated into soluble and microsomal fractions. The purity of the fractions was assessed by
22
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GAPDH (a marker for the soluble/cytoplasmic fraction), PERK and SERCA (both markers for

482

microsomal fraction) and RCAS1 (a Golgi-predominant protein) (88). (G-J): MCF-10A cells

483

were fixed with 3% PFA and stained with indicated antibodies (all antibodies were generated in

484

rabbit except anti-ECD mouse antibody) followed by species-specific secondary antibodies

485

linked to complementary DNA probes to allow fluorescent probe-based detection of the PCR

486

amplification product as distinct foci. Incubation with Proximity Ligation Assay plus and minus

487

probes, followed by ligation and amplification, was carried out according to the manufacturer

488

protocol. Red dots indicate interaction. ECD and PIH1D1 served as positive control. (K): Lysates

489

from MCF-10A cells, treated or left un-treated with Thapsigargin, were subjected to IP with anti-

490

ECD antibody (left panel) or anti-GRP78 (right panel) followed by Western blotting with

491

indicated antibodies. ECD and PIH1D1(left panel) or GRP78 and PERK (right panel) served as

492

positive controls.

493
494

Figure 3. ECD regulates the PERK pathway of the UPR. (A & C): Ecd fl/fl MEFs were

495

infected with adenoviruses coding for GFP (adeno-GFP for control) or Cre (adeno-Cre) for 72h.

496

The cells were then left un-treated or treated with Thapsigargin (50 nM). Equal amount of

497

proteins was resolved on SDS-PAGE gel followed by western blotting with indicated antibodies.

498

(B): After adenoviruses infection as described in (A), cells were treated with Thapsigargin. Total

499

RNA was isolated followed by qRT-PCR with CHOP primers; Mean +/- SD and p-values from 3

500

independent experiments are indicated * p<0.05. (D): After adenoviruses infection as described

501

in (A), equal number (1,000) of wild-type (WT) or ECD-/- cells were plated in triplicate and

502

treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed after crystal

503

blue (0.5% in 25% Methanol) staining. The color retained after the wash was dissolved in 10%
23
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acetic acid and the absorbance was read at 590 nm. The graph below represents the relative

505

absorbance; Mean +/- SD and p-values from 4 independent experiments are indicated * p<0.05;

506

** p≤0.002. (E): Panc-1 cells were treated with control or ECD siRNA for 48h. Then, the cells

507

were switched to glucose-free media and cell lysates were prepared at indicated time points

508

followed by western blot with indicated antibodies. (F; H-I): ECD inducible MEFs [(Tet(O)-

509

Flag- hECD-IRESeGFP;rtTA)] or control MEFs [(Tet(O)-Flag- hECD-IRESeGFP)] were treated

510

with Dox for 48 h followed by treatment with Thapsigargin (50 nM) or Tunicamycin (50 ng/ml).

511

Cell lysates were prepared at indicated time points and equal amount of proteins was resolved on

512

SDS-PAGE gel followed by western blot with indicated antibodies. (G): Following ECD

513

induction and Thapsigargin treatment as described above, CHOP mRNA levels were assessed

514

using qRT-PCR.

515
516

Figure 4. The increased induction of GRP78 expression is required for ECD to

517

downregulate PERK signaling. (A): Ecd fl/fl MEFs were treated with adenovirus as described in

518

(Fig. 3A-C) and then the cells were treated with Thapsigargin (50 nM). Cell lysates were

519

prepared at the indicated time points. Equal amount of proteins was resolved on SDS-PAGE gel

520

followed by western blotting with indicated antibodies. (B): ECD was knocked down by siRNA

521

(20 nM) in Panc-1 cells followed by exposure to glucose-free media and cell lysates were

522

collected at indicated times points followed by western blot with indicated antibodies. (C-D):

523

Following ECD deletion (C) or ECD overexpression (D) and Thapsigargin treatment as

524

described above, the levels of GRP78 mRNA were assessed in WT (control) vs. ECD-/- (Cre-

525

adenovirus treated) or control vs. ECD over-expressing MEFs using qRT-PCR. (E): ECD was

526

knocked down in Panc-1 cells followed by cycloheximide treatment (25 uM). Cell lysates were
24
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504

prepared at indicated time points followed by western blot with indicated antibodies. (F): ECD

528

inducible MEFs and their control MEFs were treated with Dox, as described previously,

529

followed by treatment with Thapsigargin and then Cycloheximide treatment (25 uM) for

530

indicated time points. Cell lysates were prepared followed by western blotting with indicated

531

antibodies. (G): ECD overexpressing and their control MEFs were treated with GRP78 SiRNA

532

(30 nM) or control siRNA (scrambled). 24 h later, the cells were treated with Dox for 48 h to

533

induce ECD overexpression followed by Thapsigargin treatment (50 nM). Equal amount of

534

proteins was resolved on SDS-PAGE gel followed by western blotting with indicated antibodies.

535
536

Figure 5. ECD overexpression provides survival advantage. (A): ECD was induced as

537

described in (Fig. 3 and 4) followed by Thapsigargin treatment for 24 h. Equal amount of

538

proteins was resolved on SDS-PAGE gel followed by western blot with indicated antibodies.

539

(B): Following ECD induction with Dox and Thapsigargin treatment as described above, total

540

RNA was isolated and CHOP mRNA was assessed by qPCR; Mean +/- SD and p-values from 3

541

independent experiments are indicated * p<0.05. (C): After ECD induction, control and ECD

542

inducible MEFs were trypsinized and equal number of cells (1,000) were plated in triplicates. 8 h

543

later, the cells were treated with Thapsigargin for 24h. 10 days later, surviving colonies were

544

assessed by Crystal blue staining (0.5% in 25% Methanol). The color retained after the wash was

545

dissolved in 10% Acetic acid and the absorbance was read at 590 nm. The graph below

546

represents the relative absorbance; Mean +/- SD and p-values from 4 independent experiments

547

are indicated ** p≤0.002.

548
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A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP
Complex Component RUVBL1 Is Required for the Functional Role of
ECD in Cell Cycle Progression
Departments of Genetics, Cell Biology, and Anatomy,a Pathology and Microbiology,b Pharmacology and Experimental Therapeutics,c and Biochemistry and Molecular
Biology,d College of Medicine, Eppley Institute for Research in Cancer and Allied Diseases,e Fred and Pamela Buffett Cancer Center,f and Department of Biostatistics,
College of Public Health,g University of Nebraska Medical Center, Omaha, Nebraska, USA

Ecdysoneless (ECD) is an evolutionarily conserved protein whose germ line deletion is embryonic lethal. Deletion of Ecd in cells
causes cell cycle arrest, which is rescued by exogenous ECD, demonstrating a requirement of ECD for normal mammalian cell
cycle progression. However, the exact mechanism by which ECD regulates cell cycle is unknown. Here, we demonstrate that ECD
protein levels and subcellular localization are invariant during cell cycle progression, suggesting a potential role of posttranslational modifications or protein-protein interactions. Since phosphorylated ECD was recently shown to interact with the PIH1D1
adaptor component of the R2TP cochaperone complex, we examined the requirement of ECD phosphorylation in cell cycle progression. Notably, phosphorylation-deficient ECD mutants that failed to bind to PIH1D1 in vitro fully retained the ability to
interact with the R2TP complex and yet exhibited a reduced ability to rescue Ecd-deficient cells from cell cycle arrest. Biochemical analyses demonstrated an additional phosphorylation-independent interaction of ECD with the RUVBL1 component of the
R2TP complex, and this interaction is essential for ECD’s cell cycle progression function. These studies demonstrate that interaction of ECD with RUVBL1, and its CK2-mediated phosphorylation, independent of its interaction with PIH1D1, are important
for its cell cycle regulatory function.

P

recisely regulated cell proliferation is essential for embryonic
development as well as homeostasis in adult organs and tissues, whereas uncontrolled cell proliferation is a hallmark of cancer (1). A more in-depth understanding of the regulatory controls
of cell cycle progression is therefore of great interest.
The Ecd gene was originally inferred from studies of Drosophila
melanogaster ecdysoneless (or ecd) mutants that exhibit defective
development due to reduced production of the steroid hormone
ecdysone (2). Subsequent cloning of drosophila ecd helped identify a cell-autonomous role of ECD protein in cell survival aside
from its non-cell-autonomous role in ecdysis (molting) (3). However, the molecular basis of how ECD functions remains unknown
(3). The human ECD homologue was initially identified in a
screen of human open reading frames that complemented the S.
cerevisiae mutants lacking Gcr2 (glycolysis regulation 2) gene, and
it rescued the growth defect caused by reduced glycolytic enzyme
activity in Gcr2 mutants. The human gene was initially designated
HSGT1 (human suppressor of Gcr2) and was suggested to function as a coactivator of glycolytic gene transcription (4). However,
ECD protein bears no structural homology to Gcr2, and a true
ECD orthologue is absent in S. cerevisiae, suggesting that ECD
likely functions by distinct mechanisms.
We identified human ECD in a yeast two-hybrid screen of human mammary epithelial cell cDNA-encoded proteins for novel
binding partners of the human papillomavirus 16 (HPV16) E6
oncogene (5). We showed that deletion of Ecd gene in mice causes
embryonic lethality, identifying an essential role of ECD during
early embryonic development (6). Notably, Cre-mediated conditional deletion of Ecd in Ecdfl/fl mouse embryonic fibroblasts
(MEFs) led to a G1/S cell cycle arrest, and this phenotype was
rescued by the ectopic expression of human ECD (6), indicating
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an essential role of ECD in promoting cell cycle progression. We
showed that ECD can interact with the retinoblastoma (RB) protein and reduces the repression of RB on E2F transcription factors,
providing a novel mechanism by which ECD functions as a positive factor of mammalian cell cycle progression (6). Recently, ECD
was shown to play a vital role in pre mRNA splicing by interacting
with the pre-mRNA-processing-splicing factor 8 (PRPF8) (7). We
and others have shown that ECD shuttles between nucleus and the
cytoplasm, with a predominantly cytoplasmic steady-state localization due to rapid nuclear export (7, 8). Consistent with these
key cellular roles of ECD, we found that ECD is significantly overexpressed in breast and pancreatic cancers, and its overexpression
correlates positively with poor prognostic factors and poor patient
survival (9, 10).
A pulldown screen using the phospho-peptide-binding do-
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MATERIALS AND METHODS
Reagents.  protein phosphatase (catalog no. P9614) was purchased from
Sigma-Aldrich USA, and the treatment was given according to the manufacturer’s instructions. 12.5% SuperSep Phos-tag (50 mol/liter) was
purchased from Wako Laboratory Chemicals (catalog no. 195-16391).
Electrophoresis was performed according to the manufacturer’s protocol.
PreScission protease was purchased from GE Healthcare Life Sciences.
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Cell cultures. HEK-293T, MEFs, and T98G glioblastoma cell lines
were grown in DMEM (Life Technologies, Grand Island, NY) supplemented with 10% fetal calf serum. Immortal mammary epithelial cell line
76NTERT was cultured in DFCI-1 medium, as described previously (20).
U2OS cell line was cultured in ␣-minimum essential medium (␣-MEM).
The CK2 inhibitor TBB (4,5,6,7-tetrabromo-2-azabenzimidazole) was
dissolved in dimethyl sulfoxide and used at 50 M.
Plasmid constructs, site-directed mutagenesis, and transfection.
Generation of the pMSCV-puro (Clontech)-based expression constructs
for FLAG-ECD, and its truncated versions has been described previously
(6, 8). The pMSCV-puro construct expressing ECD with deletion of
amino acids 499 to 527 was generated using a thee-fragment ligation into
BglII and HpaI sites. C-terminal His6-tagged ECD truncations (1 to 567, 1
to 534, and 1 to 432) were generated through PCR amplification and
cloning into XbaI and SalI sites of pET-28b⫹ vector (Invitrogen), and
recombinant proteins were purified after expression in Escherichia coli
BL21(DE3) strain using a nickel affinity column (GE Healthcare). C-terminal His6-tagged full-length ECD was generated by cloning ECD coding
sequence into SalI and NotI sites of the pFastBac1 vector (Invitrogen),
expressed in Sf21 insect cells, and purified by using a nickel affinity column. The PIH1D1-specific and control siRNAs catalog no. Sc-97385;
Santa Cruz) were transfected into subconfluent cells using DharmaFECT1
transfection reagent (Thermo Scientific). Green fluorescent protein
(GFP)-tagged full-length or truncated ECD expression constructs in
the pGEn2 vector were generated by replacing the ST6-Gal1 insert
in the ST6-Gal1-pGEn2 construct (ST6GAL1-pXLG-NtermTCMhisStrep-DEST) (21) with PCR-amplified ECD coding sequences at the
EcoRI and HindIII sites by infusion cloning kit (Clontech). The primer
sequences used for cloning are indicated in Table S2 in the supplemental
material. Human PIH1D1 cDNA sequences clone SC321317; Origene)
were subcloned into BamHI and XhoI sites of pGEX-6p-1 for expression
as a glutathione S-transferase (GST) fusion protein in E. coli BL21. A
recombinant GST-PERK kinase domain was expressed in BL21(DE3)
cells purified as a GST fusion protein.
Point mutants of ECD were generated using a PCR-based commercial
kit (GENEART site-directed mutagenesis system; Invitrogen), according
to the manufacturer’s instructions, cloned into the pET28b⫹ vector for
His-tagged recombinant protein expression, and purified by using a
nickel affinity column. The PCR primer sequences are listed in Table S2 in
the supplemental material. All constructs were verified by sequencing.
DNA constructs were transfected in HEK-293T cells using the
X-tremeGENE transfection reagent (Roche). Retroviral infection was carried out as described previously (6).
Flow cytometry for cell cycle analysis and biochemical fractionation. 76NTERT cells were plated at 5 ⫻ 105 cells per 100-mm dish for 12
h, subjected to growth factor deprivation by culturing in growth factorfree DFCI-3 medium for 72 h (20) and released from synchrony using
growth factor-containing DFCI-1 medium (20). Half of the cells were
fixed for fluorescence-activated cell sorter (FACS) analysis after fixation in
chilled 70% ethanol and staining with propidium iodide; the remaining
cells were used for Western blotting. G2/M-to-G1 progression in MEFs
was similarly assessed using FACS analysis after nocodazole (100 ng/ml)dependent arrest in the early G2/M phase of cell cycle (22). Nuclear and
cytoplasmic fractions were prepared from cells at various times points
during cell cycle progression using the NE-PER kit (Thermo Scientific,
catalog no. 78833). Ecdflox/flox MEFs were infected with adeno-Cre-GFP or
control adeno-GFP to assess the mitotic index. Cells were collected and
fixed as described above. The cell pellet was resuspended in 100 l of
phosphate-buffered saline (PBS) containing 1% bovine serum albumin
(BSA) and 0.25 g of phospho-H3-S10 (catalog no. ab14955; Abcam) and
then incubated for 1 h at room temperature. Cells were washed in 150 l
of PBS, resuspended in Alexa Fluor 647 (catalog no. A212235; Life Technologies)-conjugated goat anti-mouse antibody diluted at a ratio of 1:300
in 100 l of PBS containing 1% BSA, and incubated at room temperature
in the dark for 30 min, followed by FACS analysis. The median fluores-
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main of PIH1D1, the adaptor component of the evolutionarily
conserved prefoldin-like cochaperone complex R2TP, recently
identified ECD as one of the binding partners (11). This interaction was shown to require dual phosphorylation of Ser-505 and
Ser-518 on ECD (11), suggesting that ECD phosphorylation may
mediate its interaction with the R2TP complex. To date, this interaction has not been demonstrated in the context of endogenous
ECD nor has a functional role of this interaction been determined.
The core R2TP complex is composed of four proteins: PIH1D1,
RPAP3, RUVBL1, and RUVBL2 (each with a number of other
names) (12). The R2TP complex is involved in the assembly of
multisubunit complexes, including the small nucleolar ribonucleoproteins, RNA polymerase II, and phosphatidylinositol
3-kinase-related kinases and their complexes (13–15). As such, the
R2TP complex is involved in a number of essential cellular processes. The closely related RUVBL1 and RUVBL2 proteins are
AAA⫹ (ATPases associated with diverse cellular activities) that
are essential for R2TP function (16). Recent studies have shown
that RUVBL1 (Pontin) plays an important role in cell cycle regulation (17, 18). Germ line deletion of Ruvbl1 was shown to be early
embryonic lethal (18, 19). Depletion of RUVBL1 in AML1-ETO
fusion oncogene-expressing leukemic cells was shown to cause
cell cycle arrest (17) and Cre-mediated deletion of Ruvbl1 in
Ruvbl1fl/fl cells also led to G1/S cell cycle arrest (18). The apparent
similarities in the embryonic lethality and cell cycle arrest phenotypes imparted by the loss of ECD or RUVBL1 expression suggested the likelihood that the recently described interaction with
the R2TP complex (11) may underlie the functional requirement
of ECD in cell cycle progression.
In this study, we extensively analyzed the mechanism of ECDR2TP interaction and how disabling this interaction by mutations
in ECD affects the latter’s role in cell cycle progression. We demonstrate that ECD levels and localization do not vary during cell
cycle progression. We show that casein kinase 2 (CK2) phosphor
ylates ECD in cells at 6 major sites and a mutant ECD (6S/A)
disabled for CK2-mediated phosphorylation exhibits reduced
ability to rescue the cell cycle arrest caused by Ecd gene deletion.
Notably, whereas ECD can interact with PIH1D1, loss of this interaction by mutating CK2 phosphorylation sites did not impact
the ECD-R2TP association in cells. We identified a novel interaction of ECD with RUVBL1, independent of ECD’s interaction
with PIH1D1, which we show to be essential for ECD’s cell
cycle progression function. Notably, a phosphomimetic mutant (6S/D) of ECD failed to bind PIH1D1 and was incompetent at
rescuing the cell cycle arrest caused by Ecd gene deletion, suggesting a potential accessory role for PIH1D1-ECD interaction. Taken
together, our results demonstrate that although CK2-mediated
phosphorylation of ECD is important for its role in cell cycle progression, ECD’s interaction with PIH1D1 is dispensable, suggesting that the novel RUVBL1-ECD interaction that we identified is
particularly critical for ECD’s function in cell cycle.
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precipitated proteins were resolved on 7.5% SDS-polyacrylamide gels,
transferred to PVDF membranes, and visualized by autoradiography.
In vitro binding assays. GST-or His-tagged protein pulldowns were
performed as described previously (6). FLAG-tagged wild-type (WT)
ECD or its mutants (3S/A and 6S/A) were expressed by transient transfection in 293T cells and lysed in CHAPS lysis buffer as described above.
Then, 1,000 g of lysate protein was incubated with 2 g of bead-bound
purified GST-PIH1D1 for 2 h at room temperature, followed by five
washes, and then the bound proteins were detected by Western blotting
with anti-FLAG antibody. Membranes were stained with Ponceau S to
visualize the GST fusion proteins. In vitro tandem affinity purification
(TAP) was performed as described previously (23) using purified recombinant ECD with a C-terminal FLAG tag.
Cell proliferation and colony formation assays. The cell proliferation
was analyzed as described previously (6). Briefly, Ecdflox/flox MEFs were
infected with adenoviruses encoding GFP-Cre or GFP (control) (University of Iowa Gene Transfer Vector Core) and plated at 104 cells/well in
six-well plates, followed by counting of cells at the indicated time points.
For assessing colony formation ability, infected cells were plated at 5,000
or 1,000 per well in six-well plates for 10 days, the colonies were stained
with crystal violet (0.5% crystal violet in 25% methanol) and solubilized in
10% acetic acid, and then the extent of colony formation was measured by
determining the absorbance at 590 nm.
Statistical analysis. A generalized estimating equation method was
used to assess the differences among cell types accounting for the correlated measurement within a sample. Comparisons between the WT and
other cell types at a given time were made with a simulation correction
(random sampling from a probability distribution). Some results were
analyzed using a paired two-tailed Student t test. P values of ⱕ0.05 were
considered statistically significant.

RESULTS

ECD levels and localization do not change during cell cycle progression. Given the requirement of ECD for cell cycle progression and its direct association with RB (6), we assessed whether
ECD levels or localization are altered during cell cycle progression. For this purpose, an immortal mammary epithelial cell
line, 76NTERT, was arrested in the G1 cell cycle phase by growth
factor deprivation, and the cells were then allowed to proceed
synchronously though cell cycle phases by culture in regular
growth factor-containing medium. FACS analyses showed that a
majority of growth factor-deprived cells were growth arrested,
with 98% cells in the G1 phase, and only 0.75% cells in the S phase
and 1.25% cells in the G2/M phase (Fig. 1A). Western blotting of
lysates showed no significant differences in the levels of ECD protein in cells at various times during cell cycle progression (Fig. 1B).
Analysis of nuclear and cytoplasmic fractions prepared at various
times during cell cycle progression showed that ECD localizes primarily in the cytoplasm (Fig. 1C), which is consistent with its
rapid nuclear export, as previously reported (8). Overall, our results indicate that ECD levels and its subcellular localization do
not change significantly during cell cycle progression.
ECD is phosphorylated on serine residues, but overall phosphorylation does not change during cell cycle progression.
Given the known roles of phosphorylation in regulating the cell
cycle machinery (24), we sought to determine whether ECD is a
phosphoprotein and whether its phosphorylation varies with cell
cycle progression. For these analyses, T98G cells (a human brain
glioblastoma cell line that expresses a wild-type RB) (25) were
cultured in low-serum medium for 48 h to induce growth arrest
and then allowed to progress though cell cycle by adding serumcontaining medium with 32P-labeled sodium orthophosphate.
Autoradiography of anti-ECD immunoprecipitates showed that
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cence intensity (MFI) of GFP-positive cells at 488- and 633-nm wavelengths was recorded as an indicator of mitosis in the control and Ecd-null
cells.
Immunoblotting and IP. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris [pH 7.2], 150 mM NaCl, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]),
and the protein concentration was measured using the bicinchoninic
acid (BCA) protein assay reagent (Pierce). Immunoblotting was performed with primary antibodies against ECD (9), RB (catalog no.
554136; Pharmingen), anti-phospho-Ser (05-1000; Millipore), antiphospho-Thr (AB1607; Millipore), PIH1D1 (sc-101000 or sc-390810;
Santa Cruz), RUVBL1 (12300S [Cell Signaling] or SAB4200194 [Sigma])
RUVBL2 (ab36569; Abcam), RPAP3 (HPA038311; Sigma), PARP (sc8007; Santa Cruz), histone H3 (06-755; Millipore), PRPF8 (ab137694;
Abcam), ␤-actin (A5441; Sigma), or ␣-tubulin (T6199; Sigma), as indicated. For immunoprecipitations (IPs), the cells were lysed in NP-40 lysis
buffer (20 mM Tris-HCl [pH 7.5], 200 mM NaCl, 0.5% Nonidet P-40
[NP-40], 1 mM NaF, 0.1 mM Na3VO4, and protease inhibitor mixture
[Roche Applied Science]) and then immunoprecipitated with 3 g of
antibodies against ECD or 35 l of Ezview red anti-FLAG M2 affinity gel
(Sigma) for 2 h to overnight at 4°C. The immune complexes were captured with protein A/G-agarose (sc-2003; Santa Cruz Biotechnology). To
elute FLAG-tagged proteins from anti-FLAG beads before analysis, immune complexes were incubated with 150 ng of 3⫻ FLAG peptide (Sigma)/l for 15 min at room temperature, and the supernatants were collected for SDS-PAGE. For PIH1D1 interaction with ECD, the cell lysates
were prepared in CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]1-propanesulfonate} lysis buffer (0.3% CHAPS, 0.20 mM Tris-HCl [pH
7.4], 120 mM NaCl, 10% glycerol, 5 mM EDTA) supplemented with protease and phosphatase inhibitor (Roche). RUVBL1 immunoprecipitation
to assess association with ECD was carried out using a monoclonal antiRUVBL1 antibody (catalog no. SAB4200194-200UL [Sigma]; 2 g). Immunoprecipitated RUVBL1 (close to IgG heavy chain) was detected by Western blotting with an anti-RUVBL1 antibody (catalog no. 12300s; Cell
Signaling) that was conjugated to horseradish peroxidase (HRP) using the
Lightning-Link HRP conjugation kit (Novus Biologicals).
In vitro kinase assay. A total of 500 ng of purified recombinant ECD
proteins or its mutants was incubated with 0.2 mM ATP, 1 Ci of [␥32
P]ATP (Perkin-Elmer), and 0.2 l (10 U) of human recombinant CK2
(NEB, Beverly, MA) at 30°C for 30 min or as indicated. The reaction was
stopped by adding SDS-PAGE sample buffer. The 32P-labeled proteins
were detected by autoradiography after SDS-PAGE and then transfer to
polyvinylidene difluoride (PVDF) membranes (Millipore). Once the radioactive signals had decayed, the membranes were blotted with antip-Ser antibodies. Ten nanograms of recombinant GST-PERK kinase
domain was autophosphorylated in kinase assay buffer (50 mM HEPES
[pH 8.0], 10 mM MgCl2, 2.5 mM EGTA) supplemented with 20 M cold
ATP (NEB). Next, 0.5 ng was loaded onto SDS-PAGE gels and subjected
to Western blotting with anti-p-Ser and anti-p-Thr antibodies.
32
P metabolic labeling and immunoprecipitation. Exponentially
growing or serum-deprived T98G cells were washed with phosphate-free
Dulbecco modified Eagle medium (DMEM) supplemented with 10% dialyzed fetal bovine serum and incubated in the same medium for 1 h
before adding 0.1 mCi of [32P]orthophosphate (NEN) per 10-cm plate.
The cells were labeled for 4 h at 37°C (or for 2, 5, or 16 h for cell cycle
analyses), rinsed once in ice-cold PBS, and lysed in ice-cold lysis buffer
(250 mM NaCl, 1% NP-40, 20 mM Tris-HCl [pH 7.4], 1 mM EDTA, 2 g
of aprotinin/ml, 2 g of leupeptin/ml, 1 g of pepstatin/ml, 2.5 g of
antipain/ml, 1 g of chymostatin/ml, 1 mM Na3VO4, 10 mM NaF, 1 mM
sodium molybdate, 0.5 mM phenylmethylsulfonyl fluoride). Labeled
ECD was immunoprecipitated with affinity-purified mouse anti-Ecd
monoclonal antibody or anti-FLAG beads overnight at 4°C, and Protein G
Plus/Protein A-agarose beads were added for 1 h. The beads were washed
thee times with ice-cold wash buffer (150 mM NaCl, 1% NP-40, 20 mM
Tris-HCl [pH 7.4], 1 mM EDTA, and protease inhibitors). The immuno-
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DFCI-3 medium for 72 h and then switched to growth factor-containing DFCI-1 medium to initiate cell cycle progression. (A) Cells were fixed in 70% ethanol
at the indicated time points, stained with propidium iodide, and subjected to FACS analysis. (B) Lysates were collected at the indicated time points and subjected
to Western blotting for ECD or ␤-actin. ImageJ software was used to quantify ECD signals at various time points during cell cycle progression and expressed as
relative to ␤-actin signals. (C) Nuclear (N) and cytoplasmic (C) fractions were isolated from cells at various time points during cell cycle progression and
subjected to Western blot analysis with anti-ECD antibody. PARP and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) served as positive controls for
nuclear and cytoplasmic proteins, respectively. All experiments were carried out in triplicate. H.E., higher exposure.

ECD is indeed a phosphoprotein; however, the levels of phosphorylation were comparable at various time points during cell cycle
progression (Fig. 2A). As a control, RB showed an expected cell
cycle-related increase in phosphorylation at the 16- and 20-h time
points (Fig. 2A). Further analyses using anti-FLAG immunoprecipitations (IPs) from [32P]orthophosphate-labeled cells expressing an exogenous FLAG-tagged ECD protein confirmed the phosphorylation of ECD in cells (Fig. 2B). These analyses demonstrate
that ECD is a phosphoprotein; however, the phosphorylation levels do not change during cell cycle progression.
It was reported that a peptide sequence derived from ECD was
phosphorylated by casein kinase 2 (CK2) in vitro (11). To assess
whether the phosphorylation of ECD corresponds to phosphoserine (p-Ser) or phosphothreonine (p-Thr) residues, anti-FLAG
immunoprecipitates of T98G cells expressing a FLAG-tagged ECD
were blotted with anti-p-Ser or anti-p-Thr antibodies. A recombinant GST-PERK kinase domain, known to undergo autophosphorylation on serine and threonine residues during an in vitro
kinase reaction (26), was used as a positive control for serine and
threonine phosphorylation. Indeed, both p-Ser and p-Thr signals
were detected by blotting of autophosphorylated GST-PERK kinase domain (Fig. 2C). Although no signals were detected with
anti-p-Thr antibody blotting of anti-ECD immunoprecipitation,
even after long exposures, a specific band was observed with the
anti-p-Ser antibody (Fig. 2C). These results suggested that cellular
ECD is predominantly phosphorylated on serine residues.
CK2-mediated phosphorylation of ECD is important for its
cell cycle regulation function. In view of our results presented
above, and a recent study that used an array of spotted peptides to
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identify CK2 phosphorylation of an ECD peptide on Ser-505 and
Ser-518 (11), we performed a detailed analysis of potential phosphorylation sites on ECD using the publically available KinasePhos 2.0 tool (http://kinasephos2.mbc.nctu.edu.tw/). This analysis identified multiple sites on ECD that could be phosphorylated
by various Ser/Thr kinases. Among these, CK2 was predicted to
preferentially phosphorylate multiple serine residues, and this was
of obvious interest in view of our results that cellular ECD is primarily phosphorylated on Ser residues (Fig. 2C). The potential
CK2 phosphorylation sites near the C terminus, including Ser-505
and Ser-518 reported in the peptide array screen (11), were predicted with the highest confidence (Fig. 3A). To directly assess
whether ECD is a CK2 substrate, we performed an in vitro kinase
assay with purified CK2 and recombinant full-length ECD protein
or its C-terminal truncated versions. Phosphorylation was observed with full-length ECD (residues 1 to 644) and its fragments
encompassing residues 1 to 567 or 1 to 534, whereas substantially
less phosphorylation was observed with the ECD 1-432 fragment
(Fig. 3A and B). These results indicated that ECD was indeed a
substrate for CK2 in vitro and that CK2-dependent phosphorylation occurs predominantly within the C-terminal region of ECD.
CK2 is known to phosphorylate its substrates in clusters, with
phosphorylation at one site priming the substrate for phosphorylation at additional sites (27, 28). The C-terminal region contains
two potential Ser clusters: a proximal cluster of S503, S505, and
S518 and a distal cluster of S572, S579, and S584 (Fig. 3C). To
assess the contribution of these clusters to CK2-dependent phosphorylation of ECD, we introduced Ser-to-Ala mutations in these
residues, individually as well as in combinations (Fig. 3C and D).
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FIG 1 ECD localization and expression do not change during cell cycle progression. 76NTERT cells were cell cycle arrested by culturing in growth factor-free
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cultured for indicated times in complete DMEM containing 100 Ci of sodium [32P]orthophosphate per 10-cm plate. ECD or RB (used as a positive control)
were immunoprecipitated, resolved by SDS-PAGE, transferred to a PVDF membrane, and subjected to autoradiography to detect the phosphorylation signal. (B)
T98G cells transiently transfected to express FLAG-tagged ECD were cultured for 6 h in phosphate-free DMEM and then metabolically 32P labeled, as described
above. Anti-FLAG IPs were visualized by autoradiography. (C) Anti-FLAG IPs of T98G cells transfected with FLAG-tagged ECD were Western blotted with
anti-p-Ser or anti-p-Thr antibodies. In vitro-phosphorylated GST-PERK kinase domain was used as a positive control for serine and threonine phosphorylation.
The extra band observed in GST-PERK lane is likely a cleavage product of PERK. Arrows point to bands of interest.

While S¡A mutations of the Ser residues in the distal cluster
(S572A, S579A, and S584A; designated 3=S/A) had no appreciable
impact on the level of phosphorylation in the in vitro kinase assay,
similar mutations in the proximal cluster (S503A, S505A, and
S518A; designated 3S/A) led to a considerable reduction in the
CK2-mediated phosphorylation (Fig. 3D). Importantly, Ala mutations of all six residues (S503, S505, S518, S572, S579, and S584;
designated 6S/A) nearly completely abolished the CK2-mediated
in vitro phosphorylation of ECD (Fig. 3D). The autoradiography
results were confirmed by subjecting the same filters to blotting
with anti-p-Ser antibody (Fig. 3D). Since we did not observe a
shift in the mobility of the 6S/A mutant on regular SDS-PAGE,
perhaps reflecting a mechanism previously reported by Lee et al.
(29), we performed gel analysis of in vitro-phosphorylated WT,
6S/A, and phosphatase-treated WT ECD after reacting these with
Phos-tag, a dinuclear metal complex that acts as a phosphatebinding tag and can produce a mobility shift (30). As expected, the
Phos-tag-bound WT ECD resolved as a slower-migrating band
compared to its phosphatase-treated sample; notably, the 6S/A
mutant exhibited a faster mobility compared to phosphorylated
WT ECD (Fig. S1A). Collectively, these results show that the Cterminal Ser clusters of ECD, especially the proximal one, can be
phosphorylated by CK2. The small residual phosphorylation signal observed with the 6S/A mutant of ECD may reflect an additional minor site of CK2-mediated phosphorylation.
Although these experiments confirmed and extended the concept of CK2-mediated phosphorylation of ECD in vitro, to relate
this posttranslational modification to ECD function, it was important to assess whether ECD is phosphorylated in cells on the
same sites and whether such phosphorylation is important for its

890

mcb.asm.org

function. Thus, we generated pMSCV-puro vector-based retroviral constructs encoding FLAG-tagged wild type or 3S/A or 6S/A
mutants of ECD. These constructs were expressed in T98G cells,
and cells were metabolically labeled with [32P]orthophosphate.
Equal amounts of radioactive extracts (based on the counts per
minute) were subjected to anti-FLAG IP, followed by autoradiography. Although the phosphorylation signal observed with the
3S/A mutant was comparable to that on the WT ECD, the level of
phosphorylation on the 6S/A mutant was markedly reduced (Fig.
3E). To ascertain whether the defective phosphorylation of the
cell-expressed 6S/A mutant reflects simply a lack of phosphorylation of the distal serine cluster, we compared the levels of phosphorylation of FLAG-tagged WT versus 3=S/A mutant by anti-pSer immunoblotting of anti-FLAG IPs of lysates of T98G cells
transfected with the respective constructs. We did not observe any
significant differences in the anti-p-Ser signals of WT ECD versus
its 3=S/A mutant (Fig. S1B). These results establish that the two
serine clusters in ECD identified in vitro as CK2 substrate sites are
the major sites of phosphorylation in cells. Next, T98G cells expressing FLAG-tagged WT, 3S/A, and 6S/A ECD proteins were left
untreated or treated with a CK2-specific inhibitor TBB and their
anti-FLAG IPs were blotted with anti-p-Ser antibody (Fig. 3F).
Notably, CK2 inhibition reduced the phosphorylation signal in
cells expressing the WT ECD or its 3S/A mutant; however, cells
expressing the 6S/A mutant did not exhibit any change in phosphorylation (Fig. 3F), indicating that CK2 is the primary cellular
kinase responsible for the phosphorylation of ECD on two major
serine clusters characterized here. However, it remains possible
that the additional Ser or Thr residues of ECD are phosphorylated
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FIG 2 ECD is phosphorylated, predominantly on serine residues. (A) T98G cells were serum-deprived for 48 h, the last 4 h in phosphate-free medium, and then
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FIG 3 Phosphorylation of ECD is important for its ability to rescue cell cycle arrest in Ecd-null MEFs. (A) Schematic of ECD protein, its C-terminal deleted
constructs, and CK2 phosphorylation sites predicted by the KinasePhos 0.2 tool (http://kinasephos2.mbc.nctu.edu.tw/). (B) ECD is predominantly phosphorylated near its C terminus. In vitro kinase reactions of full-length (aa 1 to 644) ECD and various C-terminal deletion fragments (aa 1 to 567, 1 to 534, and 1 to 432)
with human recombinant CK2 were separated by SDS-PAGE, transferred to PVDF membranes, and subjected to autoradiography to detect 32P signals. The
purity of proteins was assessed by Coomassie brilliant blue staining (CBB). (C) Schematic representation of various point mutants. Black rectangles, WT Ser
residues; white rectangles, mutant Ala residues. (D) CK2 phosphorylates ECD at six sites. His-tagged wild-type ECD or its point mutants were purified by nickel
affinity purification and subjected to an in vitro kinase assay, as described above. 32P labeling was detected using autoradiography, and the filters were
subsequently subjected to Western blotting with anti-p-Ser antibody and reprobed with anti-ECD antibody for equal loading. The purity of recombinant
proteins was assessed by CBB staining. (E) CK2-dependent phosphorylation of ECD at multiple residues in cultured cells. T98G cells expressing FLAG-tagged
ECD or its phosphorylation site mutants 3S/A or 6S/A were metabolically labeled with 32P, as described above. FLAG-tagged ECD and its mutants were
immunoprecipitated and subjected to autoradiography. IP of cells expressing WT ECD subjected to phosphatase treatment is shown. The blot was reprobed
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3S/A and 6S/A mutants. Confirming previous findings (11), WT
ECD, but not its 3S/A or 6S/A mutant, was pulled down with
GST-PIH1D1 (Fig. 4A). These results suggested that either the
R2TP association was unnecessary for ECD function in cell cycle
progression or an alternate mechanism may recruit ECD to the
R2TP complex. To distinguish between these possibilities, we first
carried out anti-ECD IPs of U2OS and MEF cell lysates, followed
by anti-PIH1D1 blotting. These analyses confirmed the interaction of endogenous ECD and PIH1D1 (Fig. 4B and C). To examine the nature of ECD/PIH1D1 interaction in cells, we carried out
anti-PIH1D1 immunoprecipitations from HEK-293T cells expressing untagged (Fig. 4D) or GFP-tagged ECD (Fig. 4E; see also
Fig. S3A in the supplemental material), WT ECD or its phosphorylation site mutants (defective in binding to PIH1D1 in the pulldown assay), followed by blotting for ECD (Fig. 4D) or GFP (Fig.
4E, see also Fig. S3A in the supplemental material), as well as for
the four R2TP complex components (Fig. 4D and E; see also Fig.
S3A in the supplemental material). Since a phosphorylated
DSpDD/E motif, conserved between human and mouse ECD proteins (Fig. 4F), was previously found to promote the interaction of
ECD with PIH1D1 in vitro (11), we also examined a deletion construct (⌬499 –527) of ECD that lacks the DSDD/E motif in addition to the S6/A mutant lacking all CK2-phosphorylated
sites. As expected, PIH1D1 IPs were able to co-IP RPAP3,
RUVBL1, or RUVBL2 to a similar extent in all lanes (Fig. 4D
and E). Notably, compared to the levels of endogenous ECD co-IP
with PIH1D1 in vector control lanes, increased amounts of ectopically expressed ECD were coimmunoprecipitated from WT
ECD-transfected cell lysates. Unexpectedly, however, the WT and
mutant ECD proteins were coimmunoprecipitated with PIH1D1
to comparable levels (Fig. 4D and E; see also Fig. S3A in the supplemental material). These results demonstrate that ECD interacts
with the R2TP complex in cells but that the phosphorylationdependent interaction of ECD with PIH1D1 is dispensable for this
association. In further support of this conclusion, we carried out
anti-ECD and anti-PIH1D1 IPs, treated these IPs with lambda
phosphatase, and then assessed the levels of coimmunoprecipitated PIH1D1. Notably, although the phosphatase treatment robustly eliminated the phosphorylation signal on ECD (anti-p-Ser
blot), no reduction in PIH1D1or ECD coimmunoprecipitation
was seen (see Fig. S3B and C in the supplemental material). Thus,
while CK2-phosphorylated ECD can directly interact with
PIH1D1, as reported previously (11), this interaction is not required for the association of ECD with the R2TP complex. Next,
we examined the ability of 6S/D or 3=S/A mutants of ECD to
interact with PIH1D1. For this purpose, lysates from 293T cells
expressing FLAG-tagged 3=S/A or 6S/D mutants were used for an
in vitro pulldown assay with GST-PIH1D1. As expected, GSTPIH1D1 was able to pull down the 3=S/A mutant but failed to pull

with anti-ECD antibody for equal IP loading. (F) Inhibition of CK2 reduces ECD phosphorylation. T98G cells expressing FLAG-tagged ECD or its phosphorylation site mutants 3S/A and 6S/A were treated with CK2 inhibitor TBB (50 M) for 4 h, subjected to anti-FLAG IP, and Western blotted with anti-p-Ser or
anti-FLAG antibodies. The intensity of anti-p-Ser signals was quantified using ImageJ software and normalized relative to FLAG-ECD signals. (G) Phosphorylation of ECD at six CK2 sites is important for its cell cycle progression function. Ecdflox/flox MEFs stably expressing vector control, wild-type human ECD, or its
indicated mutants were infected with control (ctrl) adeno-GFP or adeno-GFP-Cre (cre) viruses for the indicated times, and lysates were analyzed by anti-ECD
and ␣-tubulin (loading control). Note that human ECD-reconstituted cells express both endogenous mouse (mEcd higher band) and ectopic hECD or its
mutants (hECD, lower band). (H to J) Analysis of hECD or its mutants for rescue of Ecdfl/fl MEFs from cell cycle arrest induced by Cre-mediated Ecd deletion.
Ecdfl/fl MEFs expressing vector (V), WT hECD or its 3S/A, 6S/A, 6S/D or 3=S/A mutants were infected with control (ctrl) or Cre adenoviruses, followed by cell
counting at the indicated time points. The Cre/Ctrl cell number ratios at each time point were plotted to assess the level of rescue relative to vector-expressing
MEFs. Simulation’s correction was applied to control for multiple testing in the calculation of the mean ratio. The experiment is representative of three repeats.
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by other kinases, depending on the cell type or varying functional
states.
Next, we assessed whether the phosphorylation of ECD on
CK2-dependent serine clusters is relevant to its cell cycle regulatory function. We have previously demonstrated that introduction of Cre recombinase in Ecdfl/fl MEFs, using adenovirus Cre,
causes G1 cell cycle arrest that is largely rescued by introducing
human ECD (6). We used this approach to compare the extent of
the rescue of cell cycle arrest induced by endogenous ECD deletion upon introducing the wild-type ECD or its phosphodefective
mutants. In initial experiments, we expressed the WT human
ECD or its 3S/A or 6S/A mutants in Ecdfl/fl MEFs (Fig. 3G) and
then assessed the ability of the cells to progress through cell cycle
without or with Cre-induced Ecd deletion. In each case, the expression of exogenous human ECD proteins and the depletion of
endogenous mouse ECD were confirmed by Western blotting
(Fig. 3G). As expected, the deletion of Ecd in Ecdfl/fl MEFs arrested
proliferation with no recovery during the entire observation period (Fig. 3H), and ectopic WT ECD significantly rescued the cells
from growth arrest (Fig. 3H; also see Fig. S2A in the supplemental
material). Notably, while the 3S/A mutant behaved comparably to
WT ECD in rescuing cells from growth arrest, the 6S/A mutant
only exhibited a partial rescue in comparison to that seen with WT
ECD in repeated experiments (P ⬍ 0.001) (Fig. 3H) (all P values
are shown in Table S1 in the supplemental material). Furthermore, we examined a mutant in which serine residues 503, 505,
and 518 were removed by deletion (⌬499 –527) in the cell cycle
rescue experiment and observed that this mutant behaved similarly to WT ECD in rescuing the proliferation block (see Fig. S2A
and B in the supplemental material). Next, we generated a phosphomimetic mutant in which the six serine residues identified to
be phosphorylated were mutated to aspartic acid residues (6S/D).
Notably, the phosphomimetic mutant 6S/D was completely defective in cell cycle rescue experiment (Fig. 3I and J). In these experiments, we also examined the 3=S/A mutant and observed a partial
rescue with this mutant (Fig. 3J). Although the complete lack of
rescue seen with the 6S/D mutant of ECD was surprising, it has
been reported that aspartic acid phosphomimics are unsuitable
for biological readouts due to different chemical properties of the
two residues (31, 32). Taken together, our results underscore the
importance of ECD phosphorylation for cell cycle progression.
Phosphodefective ECD mutants retain their ability to interact with PIH1D1 protein, as well as with other components of
the R2TP complex. In view of the complete lack of any functional
impact of mutating ECD on S503/505/518 residues, we first reexamined the previously reported dependence of ECD binding to
the isolated phospho-reader domain of PIH1D1 (11). For this
purpose, GST-PIH1D1 pulldown was carried out with lysates of
HEK-293T cells transiently transfected to express WT ECD or its

ECD-RUVBL1 Interaction Regulates the Cell Cycle

of GST-PIH1D1 with ECD and its mutants. GST-PIH1D1 was immobilized on glutathione-Sepharose beads and incubated with lysates of HEK-293 cells
expressing FLAG-tagged WT ECD or its 3S/A or 6S/A mutant. (B and C) Interaction between endogenous ECD and PIH1D1 was confirmed by immunoprecipitation of ECD from U2OS or MEFs, followed by Western blotting with anti-PIH1D1 antibody. (D and E) Lysates of HEK-293T cells transfected with untagged
(D) or GFP-tagged (E) WT, 3S/A, 6S/A, or ⌬499 –527 ECD were subjected to immunoprecipitation with anti-PIH1D1 antibody and immunoblotted with the
indicated antibodies. (F) Alignment of mouse and human ECD sequences in the region containing the DSDD/E motif. V, vector-transfected cells.

down the 6S/D mutant of ECD (see Fig. S3D in the supplemental
material), confirming that 6S/D does not mimic WT ECD for its
interaction with PIH1D1.
Novel phosphoindependent interaction of ECD with R2TP
complex through RUVBL1. Since disabling ECD binding to
PIH1D1 in the 3S/A mutant had no impact on ECD association
with the R2TP complex in cells or on ECD function during cell
cycle progression, we used an unbiased approach to identify potential mediators of ECD’s interaction with the R2TP complex.
We used an in vitro tandem affinity purification approach (23) to
identify ECD interacting partners. For this purpose, full-length
ECD was tagged with GST on the N terminus and with FLAG
epitope on the C terminus, and the twin-tagged recombinant protein was prepared in a glutathione-Sepharose bead-bound form.
Cell lysates prepared from 76NTERT cells were incubated with
these beads, and proteins in the complex were eluted by cleaving
the ECD-FLAG part of the GST-ECD-FLAG fusion on beads with
PreScission protease. The eluted ECD-FLAG, in complex with cellular proteins, was subjected to a second round of affinity purification using anti-FLAG antibody beads, and the protein complexes were eluted with a FLAG epitope peptide. The proteins in
the complex were separated by SDS-PAGE and visualized by silver
staining (Fig. 5A), and bands only seen in lanes where recombinant protein was incubated with cell lysates were excised and subjected to mass spectrometry. Proteins with Mascot scores of ⬎50
were considered potential interacting partners.
These analyses identified a known ECD binding partner PRPF8
(7) and in addition revealed several new binding partners. Interaction of PRPF8 with ECD was confirmed by immunoprecipita-
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FIG 5 ECD interacts with RUVBL1. (A) Tandem affinity purification identified RUVBL1 as an ECD-interacting protein. 76NTERT cell lysates were incubated with glutathione-Sepharose bead-bound GST-ECD-FLAG and protein
complexes eluted by cleaving the ECD-FLAG portion with PreScission protease. Eluted ECD-FLAG in complex with bound proteins was further affinity
purified using FLAG beads and then eluted using excess FLAG peptide. The
presented gel corresponds to 5% of the final eluates visualized by silver staining. Arrows point to the gel slices that were analyzed by mass spectrometry.
The top and middle arrows point to slices that identified PRPF8 and RUVBL1,
respectively. (B) Interaction between endogenous RUVBL1 and ECD. Lysates
of HEK-293T cells expressing FLAG-tagged WT ECD or its 6S/A mutant were
subjected for anti-RUVBL1 IP, followed by anti-FLAG blotting. (C) PIH1D1
knockdown does not affect RUVBL1-ECD association. Lysates of U2OS cells
transfected with PIH1D1 or scrambled control siRNA 48 h earlier were subjected to anti-ECD IP followed by blotting with antibodies against the indicated proteins. V, vector-transfected cells.
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FIG 4 ECD phosphorylation in living cells is dispensable for its interaction with PIH1D1 and other components of the R2TP complex. (A) In vitro interaction
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or His-tagged full-length ECD or its truncated mutants immobilized on glutathione-Sepharose or nickel beads, respectively, were incubated with lysates of
HEK-293T cells expressing FLAG-tagged RUVBL1. (C) Western blotting to show the expression of WT human ECD or its deletion mutants in Ecdfl/fl MEFs with
control or Cre adenovirus infection (arrowheads point to the human ECD or mutants). Also note that anti-ECD antibody blot does not detect the C-terminally
deleted ECD 1-438 mutant. (D) Colony formation assay. Ecdfl/fl MEFs expressing full-length WT ECD (aa 1 to 644) or its truncations were infected with ctrl or
Cre adenoviruses, colonies were stained with crystal violet after 10 days, and the solubilized dye absorbance was read at 590 nm. A histogram shows the relative
rescue efficiency of each construct compared to vector control cells. Error bars represent the means ⫾ the standard deviations of three independent experiments.
A statistical comparison used a Student two-tailed t test. (E) Interaction of FLAG-tagged ECD or its deletion fragments with PIH1D1. Lysates of HEK-293T cells
expressing the indicated FLAG-tagged ECD fragments were used for GST-PIH1D1 pulldown, followed by anti-FLAG blotting. V, vector-transfected cells.

tion (see Fig. S3E in the supplemental material). Among the new
partners, RUVBL1 was one of the top candidate proteins with a
Mascot score of 168. To validate the purification results, we expressed the FLAG-tagged WT ECD or its 6S/A mutant in 293T
cells and performed coimmunoprecipitation experiments with an
anti-RUVBL1 antibody. Both the WT and the 6S/A ECD proteins
were coimmunoprecipitated with RUVBL1, suggesting that ECD
interacts with RUVBL1 and that this interaction is independent of
ECD phosphorylation (Fig. 5B). To further establish that ECDRUVBL1 interaction is independent of PIH1D1, we knocked
down the endogenous PIH1D1 with siRNA and then performed a
co-IP experiment using an anti-ECD antibody. Notably, we observed equal co-IP of RUVBL1 in both control and PIH1D1
knockdown cells, confirming that ECD interaction with RUVBL1
is PIH1D1 independent (Fig. 5C). Taken together, these results
demonstrate that ECD associates with the R2TP complex though a
novel interaction with RUVBL1, independent of ECD’s interaction with PIH1D1.
Interaction with RUVBL1 is important for the role of ECD in
cell cycle progression. Germ line deletion of Ecd or Ruvbl1 is
embryonic lethal (6, 18), and silencing of either protein in cells
leads to cell cycle arrest (6, 17, 18), suggesting that interaction of
ECD with RUVBL1 may play a role in the cell cycle regulation
function of ECD. To test this hypothesis, we first expressed GFPtagged ECD or its several C-terminal deletion mutants in HEK-293T
cells and performed co-IP experiments using an anti-RUVBL1 antibody. Notably, only full-length ECD protein (amino acids [aa] 1 to
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644) coimmunoprecipitated with RUVBL1, whereas none of the Cterminal deletions of ECD was able to coimmunoprecipitate with
RUVBL1 (see Fig. S4A and B in the supplemental material). To
validate these results, we constructed several GST-tagged and Histagged ECD deletion fragments based on the predicted secondary
structure (by Garnier Robson predictions and PONDR VL-XT
secondary structure prediction) and then examined the direct interaction of these ECD mutant proteins with FLAG-RUVBL1 or
endogenous RUVBL1 using pulldown with glutathione-Sepharose or nickel beads. As shown in (Fig. 6A and B; see also Fig. S4C in
the supplemental material), only the full-length ECD interacts
with RUVBL1, whereas all C-terminal or N-terminal deletions
rendered ECD defective in binding to RUVBL1. Next, we compared various FLAG-tagged deletion fragments of ECD (residues
150 to 438, 438 to 644, 1 to 438, and 150 to 644) (see Fig. S4D in the
supplemental material) with wild-type ECD (residues 1 to 644) for
their abilities to rescue the growth arrest of Ecdfl/fl MEFs upon
adeno-Cre-mediated endogenous Ecd deletion by analyzing cell
proliferation by cell counting or colony formation (Fig. 6D). In
each case, the expression of exogenous human ECD proteins and
loss of expression of endogenous mouse Ecd in Cre-expressing
cells was confirmed using Western blotting (Fig. 6C; see also Fig.
S4D in the supplemental material). As expected, deletion of Ecd in
Ecdfl/fl MEFs arrested cell proliferation, and ectopic WT human
ECD significantly rescued the cells from growth arrest (Fig. 6D).
However, none of the deletion mutants was able to rescue the cell
proliferation block imposed by endogenous ECD depletion. These
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FIG 6 Interaction with RUVBL1 is important for ECD function in cell cycle progression. (A and B) Interaction between FLAG-RUVBL1 and ECD. GST-tagged
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anti-pH3(S10), and analyzed by flow cytometry. The median fluorescence intensity (MFI), representing the peak channel number on the x axis, is shown. (B)
Lysates of control (Ctrl) or Ecd-deleted (Cre) Ecdflox/flox MEFs were blotted with the indicated antibodies. (C) Control (Ctrl) or Ecd deletion (Cre) MEFs were
treated with 100 ng of nocodazole/ml for 20 h, and cells were switched to nocodazole-free medium to initiate cell cycle progression for the indicated time points.
The cells were stained with propidium iodide and analyzed by FACS for cell cycle analysis. (D) A graph shows the percentage of cells entering the G1 phase after
release from nocodazole treatment at various time points. Data points are means ⫾ the standard deviations of results from three independent experiments (*, P ⱕ
0.05, as determined by two-tailed Student t test). (E) The deletion of Ecd in the experiment shown in panel C was confirmed by Western blotting.

results demonstrate that only the full-length ECD, which interacts
with RUVBL1, supports cell cycle progression. The lack of rescue
with ECD deletion fragments was not due to lack of their expression (Fig. 6C; see also Fig. S4D in the supplemental material).
Notably, two deletion fragments (residues 438 to 644 and 150 to
644) that failed to rescue cell cycle arrest still retained their ability to
interact with PIH1D1 (Fig. 6E), further underscoring the conclusion
that interaction of ECD with PIH1D1 is dispensable, while its interaction with RUVBL1 is indispensable for a role in cell cycle progression. PIH1D1 is known to directly interact with other components of
the R2TP complex, such as RUVBL1 (33). Reprobing of the same
membrane with antibodies against RUVBL1 and RUVBL2 showed
the expected interaction of PIH1D1 with RUVBL1 or RUVBL2 (see
Fig. S4E in the supplemental material).
Our previous studies showed that ECD interacts with RB, a
function important for the ECD role in cell cycle progression (6).
Notably, in addition to the expected interaction of full-length
ECD with RB, one mutant (aa 150 to 644) that is defective in
rescuing cell cycle arrest (Fig. 6D) was earlier shown to retain its
ability to interact with RB (6), suggesting that interaction with
RUVBL1 is required for ECD to promote cell cycle progression
while interaction with RB in the absence of interaction with
RUVBL1 is insufficient for this function. In further support of
this conclusion cell cycle function competent (3S/A) and deficient
mutant (6S/A) of ECD show comparable interaction with RB (see
Fig. S4F in the supplemental material).
Ecd deletion leads to reduced mitotic index and delayed mitotic progression. We have previously reported that the proliferation arrest upon Ecd deletion is not associated with any increase
in apoptosis (6). To examine the effect of Ecd deletion on mitosis,

March 2016 Volume 36 Number 6

we used adeno-Cre to delete Ecd in Ecdfl/fl MEFs and measured the
MFI of phospho-histone H3 (S10) as an indicator of the proportion of cells in mitosis using flow cytometry (34). Ecd-deleted cells
showed a marked decrease in the MFI (45.7) of pH 3 (S10) compared to control cells (89.8) (Fig. 7A), indicating that Ecd deletion
cells are cell cycle arrested prior to entering mitosis. Low levels of
pH 3 (S10) were further confirmed by Western blotting (Fig. 7B).
Next, we assessed the G2/M to G1 progression of MEFs arrested in
the S phase by nocodazole treatment (Fig. 7C). Flow cytometry
analysis revealed a significant impairment in G2/M-to-G1-phase
transition upon Ecd deletion compared to control, in addition to a
higher percentage of Ecd-deleted MEFs in the G1 phase (Fig. 7C to
E). Taken together, these results demonstrate a critical role of ECD
in both G1-to-S and G2/M-to-G1 transitions. These results are
consistent with the known function of CK2 and RUVBL1 in cell
cycle regulation (35–37).
DISCUSSION

Precise regulation of the entry into, progression through, and exit
from the cell cycle is fundamental to developmental programs and
maintenance of adult tissues in multicellular organisms. Notably,
components of the cell cycle machinery and the pathways that
regulate their functions are commonly altered in cancer and other
diseases (1). Thus, elucidating how the cell cycle machinery is
controlled is an important area of research in cell and cancer biology.
We have previously shown that ECD, the mammalian orthologue of Drosophila ecdysoneless gene, is required for embryonic
development and progression of mammalian cells through the
G1-S phase of cell cycle progression (6). Here, we identify a novel
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FIG 7 Ecd deletion leads to a mitotic block. (A) Ecdflox/flox MEFs infected with control (blue) or Cre adenoviruses (red) were fixed in 70% ethanol, stained with
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ECD phosphorylation for its function that encompasses amino
acids beyond PIH1D1 interaction. Thus, the role of phosphorylation in regulating ECD function during cell cycle appears to be
independent of mediating an interaction with PIH1D1. It remains
possible, however, that phosphorylation-dependent interaction of
ECD with PIH1D1, and consequently with the R2TP complex, is
required for other functions of ECD aside from its role in promoting cell cycle progression (6). We have shown that ECD overexpression in cells leads to p53 stabilization and increased p53-dependent target gene expression and to the induction of a
senescence phenotype in primary fibroblasts (5). ECD was also
found to interact with thioredoxin-interacting protein (TXNIP),
which was shown to promote p53 stabilization (40). TXNIP has a
number of other functions, including the regulation of glucose
uptake, oxidative stress, and endoplasmic reticulum stress-induced apoptosis (41, 42), Thus, ECD phosphorylation and interaction with PIH1D1 may play a role in regulating these functions.
The availability of Ecdfl/fl MEFs in which ECD can be conditionally
deleted, together with the phosphorylation-defective mutants that
we have characterized here, should allow these notions to be tested
in the future.
In view of a novel, PIH1D1-independent mechanism of ECD
association with the R2TP complex, we sought to answer two key
mechanistic questions: first, what are the determinants of ECDR2TP association, and second, whether this unique mode of interaction is functionally relevant in the context of cell cycle progression role of ECD. Unbiased proteomics analysis of cellular
proteins that interacted with a recombinant full-length ECD protein, followed by biochemical analyses in cells, demonstrated that
ECD interacts with another component of the R2TP complex,
RUVBL1 (Fig. 5 and 6). Structure-function studies of ECD using
deletion fragments demonstrated a strong correlation between the
cell cycle progression function of ECD and its ability to interact
with RUVBL1, with only the full-length ECD competent at both
functions (Fig. 6A and B; see also Fig. S4B and C in the supplemental material). Interestingly, the ⌬499 –527 mutant which interacts with RUVBL1, but not PIH1D1, was able to rescue the cell
cycle arrest caused by Ecd deletion (see Fig. S2A in the supplemental material). Thus, our studies identify a novel interaction of ECD
with RUVBL1 and suggest that this mode of interaction with the
R2TP complex is a key to the regulation of cell cycle progression by
ECD. The delineation of sequences in ECD and RUVBL1 that
mediate their interaction should help directly test whether selective abrogation of this interaction is functionally critical in cell
cycle progression, as well as to assess the potential role of ECD in
other roles of RUVBL1 within the R2TP complex. Interestingly,
mouse ECD and RUVBL1 knockouts are phenotypically similar,
since both are embryonic lethal at the blastocyst stage (6, 19).
RUVBL1 is essential for cellular proliferation as seen in knockout
cells or upon knockdown of RUVBL1 expression (18). A recent
study demonstrated that RUVBL1 functions as a critical factor for
p300 recruitment to OCT4 target genes (18). It is of interest that
ECD also interacts with p300 and promotes its transcriptional
coactivator function (8). Thus, ECD may function in close coordination with RUVBL1.
Given the evidence we present that ECD can physically interact
with two distinct components of the R2TP complex, it is conceivable that certain ECD functions require both modes of interaction. Recent studies have shown that, aside from the R2TP complex, RUVBL1/2 are also parts of other functionally relevant
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mechanism by which ECD functions as an essential element of
mammalian cell cycle progression. Using multiple complementary approaches, we demonstrate a novel interaction of ECD with
the R2TP chaperone complex, mediated by the RUVBL1 component of R2TP, which we establish is required for ECD to promote
cell cycle progression. We also identify a role for the CK2-dependent phosphorylation of ECD in cell cycle progression. In contrast
to predictions from a previous study (11), this role is independent
of the ECD interaction with PIH1D1, the phospho-reader component of the R2TP complex.
Our findings establish that the phosphorylation of ECD positively regulates its function in promoting the cell cycle progression. Bioinformatics analysis, followed by mass spectroscopybased phosphoproteomics, identified a number of sites that could
be phosphorylated by cellular kinases, but we focused on two clusters of potential CK2 phosphorylated serine residues since a recent
study (11) showed that CK2-mediated phosphorylation of two
such serine residues in the context of a peptide created a binding
site for the phospho-reader subunit of the R2TP complex. CK2dependent phosphorylation of site-directed mutants of ECD in
vitro and in cultured cells identified six serine residues in two
spatially separated clusters to be the major CK2 phosphorylation
sites on ECD. Notably, however, ECD phosphorylation does not
change during cell cycle progression. This is not entirely surprising since our in vitro analyses, as well as phosphorylation studies in
cells in the presence of a CK2 inhibitor (Fig. 3D and F), establish
that CK2 is the predominant kinase that phosphorylates ECD;
CK2 is considered to be constitutively active and ubiquitous serine/threonine protein kinase (38). Despite its constitutive activity,
however, numerous studies point to a role for CK2 in cell proliferation and survival (39). Yet, the molecular pathways that mediate the function of CK2 in cell proliferation are largely unknown.
We suggest that phosphorylation of ECD by CK2 provides one
mechanism for CK2’s role in cell proliferation. Although the overall levels and the subcellular localization of ECD remain invariant
during cell cycle progression (Fig. 1 and 2), it remains possible that
ECD phosphorylation at specific sites may vary during cell cycle
progression. As phospho-specific antibodies against specific serine residues on ECD become available, it should be feasible to test
this notion further.
Our findings that ECD is indeed a CK2 substrate in vitro (Fig.
3) suggested that CK2-dependent phosphorylation and subsequent interaction of ECD with the R2TP complex could provide a
potential mechanism by which ECD could promote the cell cycle
transit. Our co-IP studies in cell cultures demonstrate that ECD in
fact is in a complex that includes the four core subunits of the
R2TP complex (Fig. 4D and E). Remarkably, however, multiple
mutant ECD proteins, rendered incapable of directly interacting
with PIH1D1, including mutations of critical serine residues in the
3S/A mutant or the 6S/A mutant or deletion of the region incorporating the major CK2 phosphorylation sites and the acidic motif DSDD that facilitates PIH1D1 interaction (11), fully retained
the ability to associate with the R2TP complex. Furthermore, the
ECD-R2TP association was retained in PIH1D1-depleted cells
(Fig. 5C). Thus, our results support a PIH1D1-independent
mechanism of ECD association with the R2TP complex. Importantly, S¡A mutation of ECD residues that impart PIH1D1 binding (3S/A and ⌬499 –527) had no impact on its ability to function
in cell cycle progression. However, 6S/A and 6S/D were defective
in a cell cycle rescue experiment, underscoring the importance of
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pressed ECD in tumors may function in concert with R2TP and
other RUVBL1-containing complexes to promote oncogenesis requires further investigation. Taken together, the findings presented here demonstrate that CK2-mediated phosphorylation and
interaction with RUVBL1 are essential for ECD’s ability to regulate cell cycle progression.
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complexes, such as chromatin remodeling complexes TIP60,
SWR/SRCAP, and INO80 and the Fanconi anemia core complex
that controls DNA interstrand cross-link repair and function, and
regulate telomerase biogenesis and mitosis (19, 43–45). Given the
PIH1D1-independent interaction of ECD with RUVBL1, the potential roles of ECD via these alternative complexes will be of great
future interest.
An essential role of ECD in cell cycle progression was established by our previous observation that ECD is essential for embryogenesis and its conditional deletion in MEFs leads to a G1-S
cell cycle arrest, together with an inability to initiate an E2F-dependent transcriptional program essential for cell cycle progression (6). Notably, we demonstrated that ECD competes with E2F
for binding to the pocket domain of RB and that the cell cycle
progression defect in Ecd-null MEFs could be overcome by removing the RB-mediated suppression of E2F using a pocket-binding oncogene HPV16 E7. Since a key mechanism by which the
R2TP complex regulates biochemical processes is by facilitating
protein complex remodeling, we speculate that the interaction of
ECD with the R2TP complex through RUVBL1 may facilitate the
ECD-RB complex formation and helps dissociate RB from E2Fs,
thereby derepressing the E2F-mediated transcription and promoting cell cycle progression. Consistent with this speculative
model, our previous studies showed that binding to RB was not
sufficient for the cell cycle progression function of ECD, since we
identified one ECD mutant that was able to interact with RB but
was defective in cell cycle rescue.
Our previous studies demonstrated that ECD is overexpressed
in breast and pancreatic cancer patient tissues and that ECD
overexpression correlates with poor prognosis and poor survival in breast cancer patients (9, 10). It is noteworthy that
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PIH1D1, RUVBL1, and RUVBL2, are also overexpressed in
various cancers and are predicted to play important roles in oncogenesis (46, 47). A comprehensive meta-analysis of The Cancer
Genome Atlas (TCGA) data sets (46) revealed that expression of
many RUVBL complex genes was significantly higher in breast
and colorectal carcinomas compared to their normal tissue
controls. These investigations suggested a correlation between
RUVBL complex component overexpression and increased
mTORC1 signaling and metabolic processes necessary for tumor
cell growth (46). Another study demonstrated that PIH1D1 is
overexpressed in various breast cancer cell lines, where it plays a
major role in rRNA transcription (48). Our recent studies showed
a co-oncogenic role of ECD with Ras when introduced into immortal human mammary epithelial cells (49), further suggesting
the potential collaborative role of ECD and the R2TP or other
RUVBL-containing complexes in cell cycle regulation and oncogenesis.
A positive role of ECD in pre-mRNA splicing was reported
recently based on rescue of splicing defects in the prothoracic
glands of Ecd-deficient flies by human ECD and interaction of
ECD with a complex containing the spliceosome component
PRP8 (7, 50). Our affinity purification/mass spectrometry analyses confirmed the interaction of ECD with PRPF8. The R2TP
complex regulates mRNA and ribosome biogenesis by facilitating
the assembly of small nucleolar ribonucleoproteins (snoRNPs),
which are known to be involved in spliceosome modification (51,
52). Upregulation of R2TP and snoRNP components is thought to
promote ribosome synthesis in cancer cells (47). Whether overex-
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